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TETRAHEDRON
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Abstract—1,3-Dipolar reactions of imines of both acyclic and cyclic α-amino esters with a range of nitroolefins using a combination of 
AgOAc or Ag2O with NEt3 are described. In most cases the reactions were highly regio- and stereo-specific and endo-cycloadducts were 
obtained in good yield. However, in a few cases the initially formed cycloadducts underwent base catalysed epimerisation. The 
stereochemistry of the cycloadducts was assigned from n.O.e data and established unequivocally in several cases by X-ray crystallography.   
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We introduced facile and wide ranging metal salt-tertiary 
amine catalysed cycloaddition reactions of imines, 
activated by an appropriately located carbanion stabilising 
substituent, with electron deficient alkenes.1 Subsequently, 
we have utilized this methodology for the synthesis of a 
wide variety of heterocycles including pyrrolizidines, 
indolizidines2 and spiro nitrogen heterocycles3 as well as 
the synthesis of pyrrolidine based β-lactams4, epibatidine 
analogues5a and uracil polyoxin C analogues.5b  
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Dopamine 1 is one of the most important neurotransmitters, 
the body’s natural stimulants, and plays a key role in 
schizophrenia and Parkinson’s disease. Several reports 
appear in the literature for the synthesis of both simple and 
conformationally restricted dopamine analogues6 and 
evaluation of their biological properties. Nitropyrrolidines 
are potentially useful as sources of conformationally 
restricted analogues of dopamine 1 and DOPA 27 (vide 
infra). This type of compound e.g 3-5 is accessible via 1,3-
dipolar cycloaddition of appropriate azomethine ylides and 
nitrostyrenes. Nyerges et al.8 applied this cycloaddition  
methodology to the stereoselective synthesis of aza-
cephalotaxine8a,b and indolic aza-analogues8c of 
cephalotaxine. They have also reported a new method for 
the synthesis of substituted pyrroles8d from 
nitropyrrolidines. Several authors explored the 1,3-dipolar 
cycloaddition of both non-stablized9 and stablized10 
azomethine ylides with nitroolefins for the synthesis of 
substituted nitropyrrolidines. For stabilized azomethine 
ylides it was concluded that lithio-azomethine ylides10 
undergo preferential formation of endo-cycloadducts whilst 
silver salts favour the formation of exo-cycloadducts. 
Further work showed that incorporating certain groups in 
the aromatic moiety of aryl azomethine ylides modifies the 
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stereoselectivity10b. These latter results confirmed prior 
work by our group on proton-sponge effects in azomethine 
ylide formation.11 An asymmetric catalytic version of 1,3-
dipolar cycloaddition of nitroalkenes to an imino ester 
derived from glycine has been reported12 as has microwave 
assisted synthesis of highly substituted nitroproline esters 
via 1,3-dipolar cycloaddition.13
This paper describes our studies of the silver catalysed 
synthesis of nitropyrrolidines 3 and their derivatives 4,5 all 
of which proceed via endo-transition states. The latter 
provide interesting dopamine mimetics because of the 
conformational rigidity conferred by the 5-membered ring 
and the differing dihedral angle between the aryl and amine 
moieties. We further report a series of spirocyclic 
nitropyrrolidines arising from homoserine lactone 11. 
Cycloadditions of non-cyclic imines 6a-f 
A number of nitro-olefins 7a-f were examined to explore 
the diversification of the metallo-azomethine ylide 
cycloaddition. These were prepared from the corresponding 
aryl aldehydes by the Henry reaction14 and were reacted 
with a series of aryl or aliphatic imines of cyclic or acyclic 
α-amino esters. 
The aryl imines 6a-f underwent cycloaddition reactions 
with nitroolefins in toluene in the presence of NEt3 and 
Ag2O (10 mol%) or AgOAc (1.5 mol equiv.) (Scheme 1). 
The results of the reactions are presented in Table 1. The 
cycloaddition of the less hindered imines 6a,d with 
anthracene nitrostyrene 7a afforded single cycloadducts 
endo-9a,b in good yield (72-80%)(Table 1, entries 1 and 2), 
whereas imines 6b,c from alanine and phenylalanine failed 
to react under the same conditions due to the steric 
hindrance between the Me and Bn groups of the imines and 
the anthracenyl group of the dipolarophile.  
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Table 1: Silver salt/NEt3 catalysed cycloaddition of 6a-f  with  E - nitroolefins 7a-f.a   
Entry Imine Dipolarophile Cycloadduct Ag salt Time (h) Yield (%)b
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a. Toluene, NEt3(1.5 eq.), Ag2O (10 mol%) or AgOAc (1.5 eq.), 25 °C.  
b. Isolated yield. c. 3:1 endo/exo mixture. d. 5:1 endo/exo mixture. 
e. 2:1 endo-exo mixture. 
 
Similar cycloaddition of imines 6b,c,e,f with indolyl 
nitrostyrene 7b afforded single cycloadducts 9d,e,g,h 
(Table 1, entries 4, 5, 7 and 8), whereas glycine imines 6a,d 
afforded a 3-5:1 mixture of endo-9c,f and exo-10c,f 
cycloadducts (Table 1, entries 3 and 6) respectively. Toke 
et al.10 have observed similar results in the 1,3-dipolar 
cycloaddition of glycine imine with different nitroolefins 
and they have reported that silver salts favour the formation 
of exo-cycloadduct in the case of nitroolefins with bicyclic 
aryl groups. They have suggested that secondary orbital 
interactions of the aryl groups play a major role in this 
change of stereoselectivity. This type of interaction is not 
possible in the case of imines 6 (R = Me or Bn) because of 
the steric hindrance between the bulkier groups (Me and 
Bn) of  the imines and the aryl group of the nitroolefins. 
Therefore, in all cases the cycloaddition reactions were 
overwhelmingly endo-specific.  
Figure 1 
Similarly, cycloaddition of imines 6b-e with nitroolefins 
7c-f afforded endo cycloadducts 9j-p,r-u (Table 1, entries 
10-16 and 18-21) whereas glycine imine 6a with 
nitroolefins 7c,e afforded a 2-3:1 mixture of endo-9i,q and 
exo-10i,q cycloadducts (Table 1, entries 9 and 17) 
respectively. Nitroolefin 7f reacted with alanine imine 6b 
to give a 3:1 mixture of endo-9v and exo-10v cycloadducts 
(Table 1, entry 22). 
Product structures indicate that in all cases the imines 
generate the expected metallo-1,3-dipoles 8a-f 
stereoselectively under kinetic control and the coordination 
of the metal ion depicted in 8 is believed to be responsible 
for this kinetic preference.15 The potential cycloadducts 9 
and 10 arise from the dipoles 8 via endo- and exo- 
transition states respectively. Structural assignments are 
based on 1H COSY and n.O.e data. For example, the 
methoxy signal at 3.86 ppm in 9f indicated a trans 
disposition of the ester and the indolyl groups, whilst in 10f 
the methoxy signal occurs at 3.06 ppm suggesting shielding 
of the OMe by a cis-indolyl group. This observation was 
confirmed (Fig. 1) by n.O.e experiments. Thus the 
irradiation of H-4 in 9f effects a 9.1% enhancement of the 
signal for H-5 suggesting cis relationship between H-4 and 
H-5, whereas a smaller enhancement (4.8%) of the H-3 
signal indicates H-3 and H-4 are trans related. Irradiation 
of H-2 in 9f shows no enhancement of the H-3 proton 
indicating a trans relationship between H-2 and H-3. 
Similarly irradiation of H-4 in 10f gave a small 
enhancement (1.4%) of H-5 and H-3 (3.5 %) suggesting 
trans relationship of both H-5 and H-3 with H-4 whilst 
irradiation of H-2 effected a 9.4% enhancement of H-3. 
These data suggest that H-4 and H-5 are trans-related and 
H-2 and H-3 are cis-related in 10f.  
The 5 examples of endo/exo cycloadduct mixtures 
comprise of 4 cases involving glycine imines (Table 1, 
entries 3, 6, 9, 17) and one involving an alanine imine 
(entry 22). In the former case we hypothesise that π-
stacking of the electron rich C(3)-Ar substituent and the 
C(2)-ester carbonyl group lowers the exo-transition state 
energy sufficiently to make it competitive. Factors 
favouring the exo isomer in the latter case (entry 22) are 
unclear. 
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Cycloaddition of imines 12a-f 3b of homoserine lactone 
11 
We extended our studies to spiro nitropyrrolidines 
employing metallo-azomethine ylide formation from 
aldimines of cyclic α-amino ester 11 using a combination 
of AgOAc in MeCN or Ag2O in toluene with NEt3. Imines 
of a range of aldehydes (aryl, heteroaryl, aliphatic) were 
examined to explore the diversification of the metallo-
azomethine ylide cycloaddition. In some cases imines of 
long chain aliphatic aldehydes were used to increase the 
lipophilicity of the cycloadducts. The aryl 12a-c and 
aliphatic 12d-j imines were employed in cycloadditions 
with a range of nitrostyrenes (Table 2).  
Imines 12a-c reacted with various nitrostyrenes in 
acetonitrile in the presence of triethylamine and AgOAc to 
give mixtures of 14a-c (major) and 15a-c (minor) 
cycloadducts in 59-83% yield (Scheme 2)(Table 2, entries 
1-3). The isomer ratio varied from 4.5:1 to 2:1 depending 
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on the aryl group present in the imines 12a-c. Endo 
cycloadducts 14 are formed from metallo-dipole 13 via 
endo-transition states. Cycloadducts 15 arise by the base 
catalysed epimerisation of 14. Fejes et al16 reported similar 
epimerised cycloadducts due to the strongly activated 
nature of the proton (low pKa) adjacent to the nitro-group. 
Cossio et al10b carried out similar cycloadditions with trans 
nitrostyrene using LiClO4 as catalyst and proposed a 
stepwise mechanism for the formation of this type of 
cycloadduct. 
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Table 2: Catalysed cycloaddition of imines 12a-c with E-nitrostyrene using AgOAc in MeCNa. 
 
Entry Imine R Time (h) Cycloadduct Epimer ratio Yield (%)b
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a. Acetonitrile, NEt3 (1.1 mol equiv.), AgOAc (1.5 mol equiv.), 25 °C, 4-24 h. b. Isolated yield. 
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Table 3: Catalysed cycloaddition of imines 12d-j with E-nitrostyrenes using Ag2O/NEt3 in toluenea. 
Entry Imine R Time (h) Cycloadduct dr. Yield (%)b
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a. Toluene, NEt3(1.1 mol equiv.), Ag2O (10 mol%), 25 °C, 1-5 h. b. Isolated yield. 
 
In order to rule out formation of 15 by a non-concerted 
cycloaddition, the major isomer 14a was subjected to base 
catalysed isomerisation, to probe epimerization, with the 
following results. Et3N, AgOAc, acetonitrile, 25 °C, 48 h 
gave a 3:1 mixture of 14a and 15a. The same ratio of 
isomers was obtained by changing the base to i-Pr2NEt. In 
the original reaction, carried out in acetonitrile in the 
presence of AgOAc and NEt3, the ratio of the isomers was 
3:1 after 4 h and 16 h. The observation of the same isomer 
ratio in both the original reaction and base catalysed 
isomerisation of major isomer 14a is compelling evidence 
that the formation of 15a occurs by equilibration of 14a via 
16. The pKa of the C-3 proton is expected to be ca. 10 while 
the pKa’s of the protonated amines are also approximately 
10. Equilibrium is reached between the two stereoisomers 
with steric factors favouring 14a as the major isomer 
(Scheme 3). The structure and relative stereochemistry of 
the cycloadducts 14a and 15a was partly established by 1H 
NMR, 2D-COSYH-H and n.O.e. studies (see experimental 
section). Subsequently X-ray crystallographic studies 
firmly established the stereochemical relationships (Figs. 2 
and 3).  
Aliphatic aldimines 12d-j underwent Ag2O catalysed 
cycloaddition with trans-nitrostyrene in toluene in the 
presence of NEt3 to afford the corresponding endo-
cycloadducts 14d-j in 42-85% yield (Table 3, entries 1-7). 
Cycloadducts 14e,g-j comprised 1:1 mixtures of racemic 
diastereomers (due to the chiral centre present in the side 
chain) and it was possible to separate both isomers in the 
case of 14i using silica gel chromatography. Cycloadducts 
14f comprised an inseparable 1:1 mixture of chiral 
diastereomers. In all cases the cycloaddition was regio-and 
stereo-selective and involved only the E,E-dipole 13 
(Scheme 2). The stereochemistry of the cycloadducts 14d-j 
was established by comparison of their 1H NMR spectra 
with those of the previously described analogues.3b  
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Figure 2: X-ray crystal structure of 14a 
 
Figure 3: X-ray crystal structure of 15a 
 
Reduction of nitro compounds to amines 
Several attempts at reducing the nitro moiety to the amine 
based on literature methods (ammonium formate, 10 % 
Pd/C in dry methanol,17 metal acid combinations eg, 
SnCl2/AcOH in methanol,18 In/HCl in aq. THF,19 Zn/conc. 
HCl, Fe/AcOH20) failed. However the reduction of the nitro 
group to amine was successful using Zn/ethanol/conc. HCl 
after protecting the NH of the pyrrolidine ring as the N-
acetyl derivative8b (Scheme 4). 
The reaction of the 3:1 mixture of thienyl cycloadducts 9q 
and 10q with acetic anhydride (11 mol eq) in pyridine at 0 
ºC to rt gave a 1.5:1 mixture of N-acetyl derivatives 16a 
and 16b in 66% yield. The two N-acylated isomers were 
separated by column chromatography. Close examination 
of the major product 16a showed it had undergone 
epimerisation at C-4. Thus the 1H- and 13C-NMR spectra 
were consistent with the general structure of both N-acetyl 
derivatives, but n.O.e experiments (Figure 4) were 
necessary to assign the relative disposition of the 
substituents. 
 
N
O2N
CO2CH3
S
CH3
O
H
H
H
H H
HH
3
5
4
5'
4'
3'
14.3,
14.2
10.3
3.7
2
2'
 
Figure 4. N.O.e. data of compound 16a 
 
Irradiation of 3-H and 4-H in compound 16a effects a 
14.3% and 14.2% enhancement of 4-H and 3-H 
respectively, suggesting a cis relationship between them. 
Irradiation of 2-H produced a 10.3 % enhancement of the 
thienyl 3'-H. Finally, irradiation of the methyl group of the 
N-acetyl group produced a 3.7 % enhancement of 5-H but 
no enhancement of 2-H establishing that the major solution 
phase conformer of the amide group is as shown in Figure 
4, supporting the relative disposition shown. 
Acid / base catalysed epimerisation occurred at C-4 of the 
major isomer endo-9q, facilitated by the low pKa of the 4 – 
H, to provide 16a. The C-4 epimerisation was confirmed by 
the X-ray crystal structure of 16a (Figure 5) which shows 
the naphthyl ring and the ester group on one face of the 
pyrrolidine ring and the nitro group and the thienyl ring on 
the opposite side. Additionally, distances and dihedral 
angles were calculated from the X-ray structure (Figure 5) 
to add further proof of the relative disposition of the 
substituents on the pyrrolidine ring: 2-H – 3'-H = 2.4205 Å 
and 12.18 deg , establishing that the 3-(2'-thienyl) group is 
orthogonal to the plane on the pyrrolidine ring. It was also 
found that in this crystal structure there is a disorder in the 
thiophene ring and in about half the molecules in the crystal 
the thiophene ring is rotated 180º, so that the sulphur 
occupies the position of C-3' as shown in Figure 5. 
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Figure 5: X-ray crystal structure of 16a 
The X-ray crystal structure shows that the pyrrolidine ring 
of compound 16a is in the shape of an envelope where C-4, 
bearing the nitro group, is now the atom out of the plane 
(pointing downwards on the left side of the "stick" model 
below) formed by N, C-2, C-3 and C-5 of the pyrrolidine 
ring. Calculated values for the dihedral angles from the X-
ray crystal structure of 16a are : 2-H – C-2 – C-5 – 5-H = 
150.65 deg, 5-H – C-5 – C-4 – 4-H = -36.69 deg and 4-H – 
C-4 – C-3 – 3-H = -98.55 deg. The N-acetyl group remains 
in the same plane of those four atoms, the methyl group 
oriented towards C-5. Thus the solid state orientation of the 
amide matches that established for the solution phase from 
the n.O.e. data. The 4-nitro group has a pseudo axial 
disposition while the 3-(2'-thienyl), 5-(2'-naphthyl) rings 
and 2-methyl ester group are pseudo equatorial. The 3-(2'-
thienyl) and 5-(2'-naphthyl) rings are orthogonal to the 
plane formed by N, C-2, C-3 and C-5 (Figure 6). 
 
 
Figure 6. Stick model of 16a 
 
The relative stereochemistry of the substituents minor 
isomer 16b was assigned in the same way from n.O.e. 
experiments. Irradiation of 3-H effected a 13.0% 
enhancement of 2-H, suggesting a cis relationship between 
them, and a 6.3% enhancement of 5-H. Irradiation of 4-H 
produced a 9.6% enhancement of the thienyl 4'-H. Finally, 
irradiation of 5-H led to a 4.5% enhancement of the methyl 
group of the N-acetyl group, suggesting the relative 
disposition shown on Figure 7 and establishing the same 
preferred amide orientation in both major and minor 
isomers. 
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Figure 7. N.O.e. data of compound 16b 
 
The relative disposition of the substituents in compound 
16b was confirmed by an X-ray crystal structure (Figure 8), 
which showed the 5-(2'-naphthyl) ring, 3-(2'-thienyl) ring 
and ester group are on the same face of the pyrrolidine ring. 
Calculated values for the dihedral angles from the X-ray 
crystal structure of 16b also provide further data on the 
relative orientation of the substituents: 5-H – C-5 – C-2 – 
2-H = 34.13 deg, 4-H – C-4 – C-5 – 5-H = -168.69 deg and 
3-H – C-3 – C-4 – 4-H = 158.78 deg. 
 
 
 
Figure 8: X-ray crystal structure of 16b 
As in compound 16a the 3-(2'-thienyl) and the 5-(2'-
naphthyl) rings in compound 16b are orthogonal to the 
pyrrolidine ring, and the methyl group of the acetyl group 
is oriented towards C-5 as shown in Figure 9a. 
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Figure 9. Two possible orientations of the N-acetyl 
 
The preference for orientation (a) (Figure 9) might be 
dipole-dipole interaction of the amide and ester carbonyl 
groups (Figure 10). Calculated distances, from the X-ray 
structures, confirm the proximity between the pairs of 
carbonyl carbon atoms and the corresponding oxygen 
atoms. Thus for 16a the O (carbonyl ester) – C (carbonyl 
amide) distance is 3.1914 Å, whilst the O (carbonyl amide) 
– C (carbonyl ester) distance is 3.0204 Å. In 16b the O 
(carbonyl ester) – C (carbonyl amide) distance is 3.4971 Å 
and the O (carbonyl amide) – C (carbonyl ester) distance is 
3.0731 Å. These data show the mutual orientation of the N-
acetyl groups and ester groups are consistent with π–
stacking in a manner that is dictated by dipole-dipole 
interaction (Figure 10). 
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Figure 10. Possible dipole-dipole interaction 
In 16b C-4, bearing the nitro group, is the atom out of the 
plane pointing upwards on the right side of the "stick" 
model (Fig.11) formed by N, C-2, C-3 and C-5 of the 
pyrrolidine ring, whilst the N-acetyl group is in the same 
plane as these four atoms. The 4-nitro group has a pseudo 
equatorial disposition trans to the 3-(2'-thienyl), 5-(2'-
naphthyl) rings and the 2 - ester group. These last three 
substituents are in pseudo equatorial disposition minimising 
the axial interactions. The 3-(2'-thienyl) and 5-(2'-naphthyl) 
rings are orthogonal to the plane formed by N, C-2, C-3 
and C-5 of the pyrrolidine ring (Figure 11). 
 
 
 
Figure 11.  Model of 16b 
Note that because of C-4 epimerisation compounds 16a and 
16b no longer have an endo / exo relationship. 
 
To probe the generality of C-4 epimerisation two further 
examples were studied using the same reaction conditions 
but this time starting from the single endo cycloadducts 
exo-9c and endo-9i (Scheme 4). These gave exclusively the 
N-acylated epimerised products 17a,b in 90-93 % yield. 
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NH2
O
S
endo- 9q and exo-10q, endo-9c, 9i
18a
Ac2O, 
pyridine
Zn, conc. HCl
EtOH
+
16b
16 a. Ar= 2-thienyl
17 a. Ar= 3-indolyl
     b. Ar= 4-acetoxy-3-methoxyphenyl
+
18b
 
Scheme 4 
 
In both cases the relative disposition of the substituents in 
the N-acetylated derivatives 17a and 17b were determined 
by n.O.e. experiments. It was concluded that the nitro 
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group and the C-3 aryl ring are cis-related in both 
compounds, and that there is a trans-relationship between 
the biphenyl / naphthyl rings and the nitro groups. Thus 
epimerisation at C-4 in the course of the N-acetylation 
reaction appears to be general. In the case of endo-9i the 
acetylation not only occurred at the pyrrolidine NH, but 
also at the phenolic OH. 
N.O.e. studies on 17b are summarised in Figure 12. Thus 
irradiation of 4-H produced a 9.15 % enhancement of 3-H, 
but only a 3.6 % enhancement of 5-H. Likewise irradiation 
of 3-H caused an 9.0 % enhancement of 4-H, whilst 
irradiation of 5-H gave a 3.7 % enhancement of 4-H, 
establishing a cis-relationship between 3-H and 4-H, and a 
trans-relationship between 4-H and 5-H. Finally irradiation 
of 5-H also produced a 7.7 % enhancement of the methyl of 
the N-acetyl group and no enhancement of 2-H establishing 
the same orientation of the amide as observed previously. 
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Figure 12. N.O.e data of compound 17b 
Reduction of 16a and 16b was carried out with zinc dust 
(17 mol eq) in 50:1 ethanol/conc.hydrochloric acid at 40-
50oC, then for 12 h at reflux giving the corresponding 
amino derivatives 18a and 18b in 88-95% yield. 
The relative stereochemistry of the pyrrolidine ring 
substituents in the amino derivative 18a was assigned from 
n.O.e. data. (Figure 13) Irradiation of 3-H effects an 8.6 % 
enhancement of 4-H, suggesting a cis relationship between 
them, whilst an 8.8% enhancement of the thienyl 3'-H 
occurred on irradiating 2-H. Finally, irradiation of the 
methyl of the N-acetyl group gave a 2.3% enhancement of 
5-H and no enhancement of 2-H suggesting the relative 
stereochemistry and conformation of the N-acetyl group 
shown in Figure 13. 
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Figure 13. N.O.e of compound 18a 
 
In conclusion we have shown that (i) in situ generated 
argento azomethine ylides undergo concerted cycloaddition 
to E – nitrostyrenes via endo – transition states in good 
yield (ii) the pyrrolidine ring has an envelope conformation 
with the C-4 nitro bearing carbon the out-of-plane atom 
(iii) N-acetylation with Ac2O is accompanied by C-4 
epimerisation (iv) a combination of nOe solution studies 
and X-ray crystallography show a dipole-dipole stacking 
interaction involving the C-2 ester and N-acetyl carbonyl 
groups with the methyl group of the latter oriented towards 
the C-5 aryl substituent. (v) reduction of the C-4 nitro 
group with Zn/HCl/EtOH affords the corresponding 
amines.  
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Experimental   
Melting points were determined on a Reichert hot-stage or 
Buchi B-545 apparatus and are uncorrected. Microanalysis 
was performed using a Carlo Erba MOD 1108 or 11016 
instrument. Mass spectral data were recorded on a V.G.-
AutoSpec instrument operating at 70 eV. Accurate 
molecular weights were recorded on a Micromass LCT 
KAIII electrospray (ES) machine. Infra-red spectra were 
recorded either on KBr discs or on films, prepared by 
evaporation of a dichloromethane solution, on a Nicolet 
Magna FT-IR or Nicolet 460ESP FT-IR Spectrometer. 
Nuclear magnetic resonance spectra were recorded at 250 
MHz on a Bruker AC250 instrument or at 300 MHz on a 
Bruker DPX300 or at 500 MHz on a Bruker DRX500 
instrument. Chemical shifts (δ) are given in parts per 
million (ppm). Deuterochloroform was used as the solvent 
unless otherwise stated. The following abbreviations are 
used: s = singlet, d = doublet, t = triplet, q = quartet, dd = 
double doublet, dt = double triplet, ddd = double double 
doublet, m = multiplet, b = broad, app = apparent. Flash 
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chromatography was performed either with silica gel 60 
(230-400 mesh) or with 10 g/20 g SPE-Anachem SI Mega 
Bond-Elut. All solvents were purified according to standard 
procedures. The term ether refers to diethyl ether. 
Analytical grade anhydrous silver salts were used as 
purchased. In all reactions involving silver (I) salts the 
reaction flask was covered with aluminium foil. 
General Procedure for Silver(I) Catalysed 
Cycloaddition Reactions  
The appropriate aldimine (1 mol equiv.), triethylamine, 
dipolarophile (1 mol equiv.) and silver acetate (1.5 mol 
equiv.) were mixed in freshly distilled acetonitrile. Silver 
oxide (10 mol%) as metal catalyst and toluene (dried over 
sodium wire) as solvent were used in the case of aliphatic 
aldimines. The resulting suspension was stirred for an 
appropriate period at room temperature (monitored by TLC 
and 1H NMR). After completion of the reaction the mixture 
was quenched with saturated aqueous ammonium chloride 
and extracted with ether or dichloromethane (2 x). The 
dried (magnesium sulphate) organic layer was concentrated 
under reduced pressure. The ratio of any isomers present in 
the residue was calculated from the integrals of appropriate 
peaks in the 1H NMR spectrum. Flash chromatography 
afforded the individual stereoisomers when present. 
Methyl 3-(9-anthryl)-5-(2-naphthyl)-4-nitro-prolinate 
(9a) Obtained from imine 6a (227 mg, 1 mmol), E-
nitrostyrene 7a (249 mg, 1 mmol), triethylamine (0.21 mL, 
1.5 mmol) and silver acetate (250 mg, 1.5 mmol) in toluene 
(20 mL) over 18 h. Purification was achieved by triturating 
with ether and filtering to afford the product (380 mg, 80%) 
as a pale yellow amorphous solid, m.p. 130-132 °C. Found: 
C, 75.35; H, 5.15; N, 5.75. C30H24N2O4 requires C, 75.60; 
H, 5.10; N, 5.90 %; δ (1H, 250 MHz): 8.51 (s, 1H, ArH), 
8.00-7.50 (m, 15H, ArH), 6.17 (dd, 1H, J 6.2 and 7.5 Hz, 4-
H), 6.01 (dd, 1H, J 6.2 and 9.7 Hz, 3-H), 5.76 (d, 1H, J 7.5 
Hz, 5-H), 4.81 (d, 1H, J 9.7 Hz, 2-H), 3.60 (bt, 1H, J 9.7 
Hz, NH) and 3.48 (s, 3H, OMe); δ (13C): 172.4 (CO), 
133.8, 133.5, 132.6, 129.8 (Cq), 129.7, 128.9, 128.6, 128.2 
(2 x ArCH), 127.6, 127.0 (Cq), 126.9, 126.4, 124.7, 123.5 
(2 x ArCH), 97.7 (C4), 68.2 (C2), 66.1 (C3), 52.9 (C5) and 
50.8 (OCH3); νmax (KBr): 3057, 1737, 1557, 1266, 1214 
and 756 cm-1; m/z(%): 476 (M+., 20), 427 (20), 370 (50) 
and 202 (100); m/z (ES+): 500 (M+.+1+Na), 499 (M+.+Na), 
477 (M+.+1, 100). 
 
 
 
 
Methyl 3-(9-anthryl)-5-(1,1′-biphenyl-4-yl)-4-nitro-
prolinate (9b) Obtained from imine 6d (253 mg, 1 mmol), 
E-nitrostyrene 7a (249 mg, 1 mmol), triethylamine (0.21 
mL, 1.5 mmol) and silver acetate (250 mg, 1.5 mmol) in 
toluene (20 mL) over 18 h. Purification by flash 
chromatography eluting with DCM/ hexane (20%) afforded 
the product (361 mg, 72%) as a pale yellow powder, m.p. 
270-272 °C. Found: C, 76.55; H, 5.25; N, 5.45. C32H26N2O4 
requires C, 76.50; H, 5.20; N, 5.55 %; δ (1H, 250 MHz): 
8.50 (s, 1H, ArH), 8.34-7.97 (m, 5H, ArH), 7.95-7.80 (m, 
3H, ArH), 7.75-7.39 (m, 7H, ArH), 7.30-7.05 (m, 2H, 
ArH), 6.17 (dd, 1H, J 6.3 and 7.5Hz, 4-H), 6.00 (dd, 1H, J 
6.3 and 9.8Hz, 3-H), 5.74 (d, 1H, J 7.5Hz, 5-H), 4.81 (d, 
1H, J 9.8Hz, 2-H), 3.48 (s, 3H, OMe) and 2.35 (s, 1H, NH); 
δ (13C): 172.4 (CO), 133.8, 133.5, 132.6 (Cq), 129.7 (2 x 
ArCH), 129.5 (2 x Cq), 128.9 (2 x ArCH), 128.6 (4 x 
ArCH), 128.2 (2 x ArCH), 127.6 (Cq), 127.0 (2 x ArCH), 
126.9 (Cq), 126.4 (2 x ArCH), 125.7 (Cq), 124.7, 123.5 (2 x 
ArCH), 97.7 (C4), 68.2 (C2), 66.1 (C3), 52.9 (C5) and 50.8 
(OCH3); νmax (KBr): 3353, 3053, 3031, 2953, 2849, 1737, 
1557, 1438, 1231, 891, 765, 730, and 700 cm-1; m/z (ES+): 
502 (M+., 100). 
Methyl 3-(1H-indol-3-yl)-5-(2-naphthyl)-4-nitro-
prolinate (9c and 10c) Obtained from imine 6a (227 mg, 1 
mmol), E-nitrostyrene 7b (188 mg, 1 mmol), triethylamine 
(0.21 mL, 1.5 mmol) and silver acetate (250 mg, 1.5 mmol) 
in toluene (20 mL) over 18 h. Purification by cartridge 
column SPE-Anachem 20g SI Mega Bond-Elut eluting 
with 100% hexane to 100% ethyl acetate gradient elution 
afforded first endo-9c (291 mg, 70%), followed by exo-10c 
(104 mg, 25%).  
endo-9c: Obtained as colourless plates, m.p. 163-165 °C. 
Found: C, 69.25; H, 5.15; N, 9.85. C24H21N3O4 requires C, 
69.40; H, 5.10; N, 10.10 %; δ (1H, 300 MHz): 10.50 (bs, 
1H, indole NH), 7.88-7.11 (m, 12H, ArH), 5.49 (dd, 1H, J 
2.8 and 5.9 Hz, 4-H), 5.11 (dd, 1H, J 5.9 and 10.9 Hz, 5-H), 
4.57 (dd, 1H, J 3.0 and 7.2 Hz, 3-H), 4.44 (2 x overlapping 
d, 1H, J 9.0, 7.0 Hz, 2-H), 3.82 (s, 3H, OMe) and 3.62 (t, 
1H, J 10.9 Hz, NH); δ (13C): 172.6 (CO), 137.1, 133.6, 
133.5, 132.0 (Cq), 128.9, 128.5, 128.0 (ArCH), 126.8 (2 x 
 % Enhancement 
Irradiated proton H-1 H-2 H-3 H-4 H-5 
H-2 2.5  - - 3.2 
H-3 0.8 -  - - 
H-4 - - -  6.0 
H-5 - 4.2 - 8.8  
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ArCH), 126.3 (Cq), 125.9 124.4, 123.5, 122.3, 120.8, 119.0 
(ArCH), 114.0 (Cq), 112.1 (ArCH), 96.4 (C4), 67.8 (C2), 
65.9 (C3), 53.1 (C5) and 48.7 (OCH3); νmax (KBr): 3328, 
3057, 1733, 1552, 1384, 1215,1112 and 747 cm-1; m/z 
(ES): 416 (M+.+1), 414 (M+.-1). 
 
nOe data for 9c: 
 
exo-10c: Obtained as pale orange plates, m.p. 207-209 °C. 
Found: C, 69.45; H, 5.15; N, 10.00. C24H21N3O4 requires C, 
69.40; H, 5.10; N, 10.10 %; δ (1H, 300 MHz, CDCl3+2 
drops DMSO): 9.87 (bs, 1H, indole NH), 7.85-6.93 (m, 
12H, ArH), 5.27 (t, 1H, J 8.1 Hz, 4-H), 4.86 (t, 1H, J 8.1 
Hz, 5-H), 4.65 (t, 1H, J 8.1 Hz, 3-H), 4.51 (dd, 1H, J 6.7 
and 8.1 Hz, 2-H), 3.06 (s, 3H, OMe) and 2.92 (dd, 1H, J 6.7 
and 8.1 Hz, NH); δ (13C, CDCl3+2 drops d6-DMSO): 172.9 
(CO), 136.6 (Cq), 136.2 (2 x Cq), 133.7, 133.5, (Cq), 129.3, 
128.4, 128.0, 126.8, 126.7, 126.5, 124.6, 122.7, 122.3, 
119.7, 118.7, 111.9 (ArCH), 109.7 (Cq), 95.6 (C4), 67.8 
(C2), 63.9 (C3), 51.9 (C5) and 46.3 (OCH3); νmax (KBr) 
3418, 3356, 2948, 1742, 1543, 1361, 1204 and 739 cm-1; 
m/z (ES): 417 (M+.), 416 (M+.+1, 100). 
 
 
 
nOe data for exo-10c: 
 
Methyl 3-(1H-indol-3-yl)-2-methyl-5-(2-naphthyl)-4-
nitro-prolinate (9d) Obtained from imine 6b (241 mg, 1 
mmol), E-nitrostyrene 7b (188 mg, 1 mmol), triethylamine 
(0.21 mL, 1.5 mmol) and silver oxide (30 mg, 0.13 mmol) 
in toluene (20 mL) over 18 h. Purification by triturating 
with ether and filtering afforded the product (258 mg, 60%) 
as a pale orange amorphous solid, m.p. 190-193 °C. Found: 
C, 70.05; H, 5.25; N, 9.80. C25H23N3O4 requires C, 69.90; 
H, 5.40; N, 9.80 %; δ (1H, 250 MHz, CDCl3+2 drops d6-
DMSO): 10.33 (bs, 1H, indole NH), 7.42 (s, 1H, ArH), 
7.33-6.50 (m, 11H, ArH), 5.43 (bt, 1H, J 7.7 Hz, 4-H), 4.80 
(bt, 1H, J 9.1 Hz, 5-H), 4.35 (bd, 1H, J 7.7 Hz, 3-H), 3.26 
(s, 3H, OMe), 3.09 (bd, 1H, J 9.1 Hz, NH), 0.75 (s, 3H, 
CH3); δ (13C, CDCl3+2 drops DMSO): 175.5 (CO), 136.6, 
133.9, 133.4, 133.2 (Cq), 128.4, 127.9 (ArCH), 127.3 (Cq), 
126.6 (2 x ArCH), 126.3, 125.1, 123.4, 122.1 119,6, 118.9, 
112.1 (ArCH), 109.9 (Cq), 96.6 (C4), 68.6 (C2), 64.4 (C3), 
53.1 (C5), 50.2 (OCH3) and 21.9 (CH3); νmax (KBr): 3070, 
3425, 1722, 1544, 1456, 1395, 1139, 855, 819 and 747 cm-
1; m/z (ES): 430 (M+.+1, 100), 428 (M+.-1, 100). 
Methyl 2-benzyl-3-(1H-indol-3-yl)-5-(2-naphthyl)-4-
nitro-prolinate (9e) Obtained from imine 6c (377 mg, 1 
mmol), E-nitrostyrene 7b (188 mg, 1 mmol), triethylamine 
(0.21 mL, 1.5 mmol) and silver oxide (30 mg, 0.13 mmol) 
in toluene (20 mL) over 18 h. Purification by flash 
chromatography eluting with 19:1 v/v dichloromethane 
/hexane afforded the product (303 mg, 60%) as pale yellow 
needles, m.p. 143-146 °C. Found (HRMS, M+ +Na): 
528.1899. C31H27N3O4Na requires: 528.1899; δ (1H, 250 
MHz): 8.30 (s, 1H, indole NH), 7.98 (s, 1H, ArH), 7.85-
7.77 (m, 4H, ArH), 7.49-7.42 (m, 4H, ArH), 7.26-7.10 (m, 
8H, ArH), 5.81 (dd, 1H, J 5.0 and 7.1 Hz, 4-H), 5.46 (dd, 
1H, J 7.1 and 9.3 Hz, 5-H), 4.90 (d, 1H, J 5.0 Hz, 3-H), 
3.75 (s, 3H, OMe), 3.53 (d, 1H, J 9.3 Hz, NH) and 2.86 
(SAB, 2H, CH2); δ (13C): 174.2 (CO), 136.7, 136.1, 133.4, 
133.2, 133 (Cq), 130.0, 128.9, 128.4, 128.2, 128.0, 127.7 
(ArCH), 127.3 (Cq), 126.8, 126.4, 126.2, 124.6, 122.8, 
120.4, 119.2, 111.6 (ArCH), 111.0 (Cq), 96.8 (C4), 73.1 
 % Enhancement 
Irradiated proton H-3 H-4 H-5 H-2΄ Aryl 
H-1 6.4 2.1 - - - 
H-2 - - 4.1 7.7 3.1 
H-3  3.9 - 2.7 3.5 
H-4 4.8  9.1 - 2.7, 4.0 
H-5 4.6 12.8  - 5.7, 2.8 
 % Enhancement 
Irradiated proton H-2 H-3 H-4 H-5 H-
2΄ 
Aryl 
H-1 5.4 - - - 5.8 4.8,4.0 
H-2  9.4 - 3.5 - - 
H-3 11.8  3.6 5.2 2.5 9.3 
H-4 - 3.5  1.5 9.2 4.1, 4.9 
H-5 3.6 4.3 -  - 10.3,3.5 
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(C2) 65.2 (C3), 52.4 (C5), 50.6 (OCH3) and 40.6 (CH2); νmax 
(KBr) 3377, 3057, 1727, 1555, 1457, 1430, 1370, 1200, 
819, 749 and 707 cm-1; m/z (ES+): 530 (M+.+2+Na), 529 
(M+.+1+Na), 506 (M+.+1, 100), (ES-) 505 (M+.), 504 (M+.-1, 
100). 
Methyl 5-(1,1'-biphenyl-4-yl)-3-(1H-indol-3-yl)-4-nitro-
prolinate (9f and 10f) Obtained from imine 6d (253 mg, 1 
mmol), E-nitrostyrene 7b (188 mg, 1 mmol), triethylamine 
(0.21 mL, 1.5 mmol) and silver oxide (30 mg, 0.13 mmol) 
in toluene (20 mL) over 18 h. Purification by SPE-
Anachem 20 g SI Mega Bond-Elut cartridge using 100% 
hexane to 100% ethyl acetate gradient elution afforded first 
endo-9f  (304 mg, 69%), followed by exo-10f (114 mg, 
26%). 
endo-9f: Obtained as colourless plates, m.p. 152-154 °C. 
Found: C, 70.80; H, 5.30; N, 9.25. C26H23N3O4 requires C, 
70.75; H, 5.25; N, 9.50 %; δ (1H, 300 MHz): 8.30 (bs, 1H, 
indole NH), 7.66-7.19 (m, 14H, ArH), 5.43 (dd, 1H, J 2.6 
and 6.0 Hz, 4-H), 4.97 (d, 1H, J 6.0 Hz, 5-H), 4.58 (dd, 1H, 
J 2.6 and 6.8 Hz, 3-H), 4.43 (d, 1H, J 6.8 Hz, 2-H), 3.85 (s, 
3H, OMe) and 3.56 (m, 1H, NH); δ (13C): 172.6 (CO), 
141.8, 140.7, 137.1, 133.7 (Cq), 129.2 (2 x ArCH), 127.9 
(ArCH), 127.8 (2 x ArCH), 127.5 (2 x ArCH), 127.2 (2 x 
ArCH), 126.3 (Cq), 123.5 (indole C2'), 122.3 (indole C5'), 
120.8 (indole C4'), 118.9 (indole C6'), 113.9 (indole C3'), 
112.1 (indole C7'), 96.5 (C4), 67.5 (C2), 65.9 (C3), 53.1 (C5) 
and 48.6 (OCH3); νmax (KBr) 3294, 3038, 2953, 2903, 
1735, 1542, 1372, 1212, 1095, 835, 765, 745 and 701 cm-1; 
m/z (ES+): 464 (M+.+Na), 443 (M+.+2), 442 (M+.+1, 100); 
(ES-): 441 (M+.), 440 (M+.-1, 100). 
exo-10f: Obtained as pale orange plates, m.p. 171-173 °C. 
Found: C, 70.50; H, 5.10; N, 9.25. C26H23N3O4 requires C, 
70.75; H, 5.25; N, 9.50 %; δ (1H, 300 MHz): 8.21 (bs, 1H, 
indole NH), 7.67-7.06 (m, 14H, ArH), 5.31 (t, 1H, J 7.9 Hz, 
4-H), 4.88 (d, 1H, J 7.9 Hz, 5-H), 4.76 (t, 1H, J 7.9 Hz, 3-
H), 4.63 (d, 1H, J 7.9 Hz, 2-H), 3.18 (s, 3H, OMe) and 2.92 
(bs, 1H, NH); δ (13C): 172.8 (CO), 142.1, 140.9, 137.6, 
136.4, 130 (Cq), 129.2 (2 x ArCH), 128.1 (2 x ArCH), 
127.9 (Cq), 127.6 (2 x ArCH), 127.5 (2 x ArCH), 123.1, 
122.2, 120.4, 119.2 (indole C2'-6'), 111.6 (indole C7'), 111.3 
(C3'), 95.8 (C4), 67.6 (C2), 64.1 (C3), 52.1 (C5) and 46.2 
(OCH3); νmax (KBr): 3382, 3059, 2954, 2873, 1743, 1547, 
1362, 1200, 909, 853, 768, 734 and 702 cm-1; m/z (ES+): 
443 (M+.+2), 442 (M+.+1, 100); (ES-): 441 (M+.), 440 (M+.-
1, 100). 
Methyl 5-(1,1'-biphenyl-4-yl)-3-(1H-indol-3-yl)-2-
methyl-4-nitro-prolinate (9g) Obtained from imine 6e 
(267 mg, 1 mmol), E-nitrostyrene 7b (188 mg, 1 mmol), 
triethylamine (0.21 mL, 1.5 mmol) and silver oxide (30 mg, 
0.13 mmol) in toluene (20 mL) over 18 h. Purification by 
flash chromatography eluting with 9:1 v/v 
dichloromethane/hexane afforded the product (327 mg, 
72%) as pale orange plates m.p. 132-136 °C. Found: C, 
71.15; H, 5.30; N, 9.15. C27H25N3O4 requires C, 71.20; H, 
5.55; N, 9.20 %; δ (1H, 250 MHz): 8.31 (bs, 1H, indole 
NH), 7.69-7.14 (m, 14H, ArH), 5.75 (dd, 1H, J 6.5 and 7.5 
Hz, 4-H), 5.21 (d, 1H, J 7.5 Hz, 5-H), 4.90 (d, 1H, J 6.5 Hz, 
3-H), 3.86 (s, 3H, OMe) and 1.32 (s, 3H, CH3); δ (13C): 
175.7 (CO), 142.0, 140.8, 136.5, 134.9 (Cq), 129.2 (2 x 
ArCH), 127.9 (ArCH), 127.8, 127.5 (3 x ArCH), 127.4 
(Cq), 123.1, 122.8, 120.6, 119.5 (indole C2'-6'), 111.9 (indole 
C7'), 111.5 (C3'), 96.8 (C4), 69.0 (C2), 64.9 (C3), 53.4 (C5), 
50.4 (OCH3) and 22.3 (CH3); νmax (KBr): 3406, 3298, 3039, 
1735, 1543, 1435, 1251, 1138, 1115, 846, 764, 745 and 700 
cm-1; m/z (%, FAB): 456 (M+.+1, 80), 308 (100), 268(85); 
m/z (ES+): 479 (M+.+1+Na), 478 (M+.+Na), 456 (M+.+1, 
100); (ES-): 455 (M+.), 454 (M+.-1). 
Methyl 2-benzyl-5-(1,1'-biphenyl-4-yl)-3-(1H-indol-3-
yl)-4-nitro-prolinate (9h) Obtained from imine 6f (343 
mg, 1 mmol), E-nitrostyrene 7b (188 mg, 1 mmol), 
triethylamine (0.21 mL, 1.5 mmol) and silver oxide (30 mg, 
0.13 mmol) in toluene (20 mL) over 18 h. Purification by 
flash chromatography eluting with 9:1 v/v 
dichloromethane/hexane afforded the product (330 mg, 
62%) as pale yellow plates, m.p. 174-178 °C. Found: C, 
74.55; H, 5.50; N, 7.90. C33H29N3O4 requires C, 74.55; H, 
5.50; N, 7.90 %; δ (1H, 250 MHz): 8.30 (bs, 1H, indole 
NH), 7.90-6.90 (m, 19H, ArH), 5.75 (dd, 1H, J 6.6 and 5.2 
Hz, 4-H), 5.34 (d, 1H, J 6.6 Hz, 5-H), 4.87 (d, 1H, J 5.2 Hz, 
3-H), 3.73 (s, 3H, OMe), 3.42 (bs, 1H, NH) and 2.84 (s, 
2H, CH2); δ (13C) 174.6 (CO), 142.1, 140.9, 137.1, 136.5, 
135.1 (Cq), 130.4, 129.2, 128.5 (2 x ArCH), 127.9, 127.8 (3 
x ArCH), 127.7 (Cq), 127.5 (2 x ArCH), 127.2, 123.2, 
120.8, 119.6, 111.9 (ArCH), 111.4 (C3'), 97.2 (C4), 73.4 
(C2), 65.2 (C3), 52.9 (C5) 50.8 (OCH3) and 41.0 (CH2); νmax 
(KBr): 3381, 3055, 2963, 1728, 1553, 1457, 1428, 1370, 
1200, 819, 748 and 706 cm-1; m/z (%, FAB+): 532 (M+.+1, 
80), 308 (100). 
Methyl 3-(4-hydroxy-3-methoxyphenyl)-5-(2-naphthyl)-
4-nitro-prolinate (9i) Obtained from imine 6a (227 mg, 1 
mmol), E-nitrostyrene 7c (195 mg, 1 mmol), triethylamine 
(0.21 mL, 1.5 mmol) and silver oxide (30 mg, 0.13 mmol) 
in toluene (20 mL) over 16 h. Trituration with 9:1 v/v 
dichloromethane/methanol and filtration afforded the 
product (177 mg, 42%) as colourless plates, m.p. 208-210 
°C. Found: C, 65.40; H, 5.25; N, 6.50. C23H22N2O6 requires 
C, 65.40; H, 5.25; N, 6.65 %; δ (1H, 300 MHz): 8.0 (bs, 
1H, OH), 7.93 (d, 1H, J 8.7 Hz, ArH), 7.86 (dd, 2H, J 6.0 
and 3.4 Hz, ArH), 7.72 (dd, 1H, ArH), 7.52 (dd, 2H, J 6.0 
and 3.4 Hz ArH), 6.85 (d, 1H, J 8.7 Hz, ArH), 6.78 (m, 2H, 
ArH), 5.70 (m, 1H, NH), 5.26 (t, 1H, J 7.7 Hz, 4-H), 4.93 
(d, 1H, J 7.7 Hz, 5-H), 4.55 (d, 1H, J 8.7 Hz, 2-H), 4.35 
(dd, 1H, J 8.7 and 7.7 Hz, 3-H), 3.84 (s, 3H, CO2Me) and 
3.42 (s, 3H, OMe); δ (1H, 250 MHz, D6 DMSO): 9.06 (s, 
1H, OH), 7.92 (m, 4H, ArH), 7.61 (dd, 1H, J 1.5 and 8.5 
Hz, ArH), 7.53 (m, 2H, ArH), 7.02 (d, 1H, J 1.8 Hz, ArH), 
6.82 (dd, 1H, J 1.8 and 8.1 Hz, ArH), 6.75 (d, 1H, J 8.1 Hz, 
ArH), 5.71 (dd, 1H, J 5.0 and 7.9 Hz, NO2CH), 5.22 (t, 1H, 
J 7.9 Hz, naphthyl-CH), 4.08 (m, 2H, H+H2), 3.93 (t, 1H, J 
7.9 Hz, phenyl-CH), 3.81 (s, 3H, CO2Me) and 3.71 (s, 3H, 
OMe); δ (13C, D6 DMSO): 172.3 (CO), 148.1, 146.4, 135.1, 
133.0, 132.9, 129.2 (Cq), 128.3, 127.9, 127.8, 126.6, 126.5, 
126.0, 125.7, 120.9, 115.8, 112.3 (ArCH), 96.5 (C4), 66.5 
(C2), 65.6 (C3), 56.1 (ArOCH3), 54.0 (CO2CH3) and 52.5 
(C5); νmax (KBr):  cm-1; m/z (ES+): 423 (M+.+1, 100). 
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Methyl 3-(4-hydroxy-3-methoxyphenyl)-2-methyl-5-(2-
naphthyl)-4-nitro-prolinate (9j) Obtained from imine 6b 
(241 mg, 1 mmol), E-nitrostyrene 7c (195 mg, 1 mmol), 
triethylamine (0.21 mL, 1.5 mmol) and silver oxide (30 mg, 
0.13 mmol) in toluene (20 mL) over 17 h. Purification by 
triturating with dichloromethane and filtering afforded the 
product (396 mg, 91%) as a pale yellow solid, m.p. 164-
166 °C. Found: C, 65.90; H, 5.55; N, 6.40. C24H24N2O6 
requires C, 66.05; H, 5.55; N, 6.40 %; δ (1H, 250 MHz, d6-
DMSO): 9.07 (s, 1H, OH), 7.96-7.87 (m, 4H, ArH), 7.64-
7.49 (m, 3H, ArH), 6.95 (d, 1H, J 1.9 Hz, ArH), 6.83 (dd, 
1H, J 1.9 and 8.2 Hz, ArH), 6.74 (d, 1H, J 8.2 Hz, ArH), 
6.27 (t, 1H, J 8.6 Hz, 4-H), 5.29 (t, 1H, J 8.6 Hz, 5-H), 4.53 
(d, 1H, J 8.6 Hz, 3-H), 3.93 (d, 1H, J 8.6 Hz, NH), 3.81 (s, 
3H, CO2Me), 3.79 (s, 3H, OMe) and 1.21 (CH3); δ (13C, 
CDCl3 +2 drops DMSO): 174.7 (CO), 147.5, 146.3, 134.0, 
133.1, 132.9 (Cq), 128.0, 127.9, 127.6 (ArCH), 126.3 (Cq), 
126.1, 125.0, 120.8, 115.4, 112.7 (ArCH), 95.0 (C4), 68.3 
(C2), 63.8 (C3), 56.1 (ArOCH3), 56.0 (CO2CH3), 52.7 (C5) 
and 21.4 (CH3); νmax (KBr): 3294, 2952, 1740, 1547, 1436, 
1264, 1128, 863, 832 and 746 cm-1; m/z (ES+): 460 
(M+.+1+Na), 437 (M+.+1, 100); (ES-): 436 (M+.), 435 (M+.-
1, 100). 
 
nOe data for 9j: 
 
 
Methyl 5-(1,1'-biphenyl-4-yl)-3-(4-hydroxy-3-
methoxyphenyl)-4-nitro-prolinate (9k) Obtained from 
imine 6d (401 mg, 1.6 mmol), E-nitrostyrene 7c (309 mg, 
1.6 mmol), triethylamine (0.33 mL, 2.4 mmol) and silver 
acetate (395 mg, 2.4 mmol) in toluene (30 mL) over 16 h. 
Purification by triturating with 9:1 v/v ethyl acetate/hexane 
afforded the product (367 mg, 82%) as a colourless solid, 
m.p. 187-190 °C. HRMS (M+ + H): 449.1710. C25H24N2O6 
requires 449.1712. δ (1H, 300 MHz, CDCl3 + 2 drops d6-
DMSO): 7.56-7.52 (m, 4H, ArH), 7.42-7.28 (m, 5H, ArH), 
6.95 (s, 1H, OH), 6.90 (d, 1H, J 7.5 Hz, ArH), 6.75 (dd, 1H, 
J 2.3 and 7.5 Hz, ArH), 6.74 (s, 1H, ArH), 5.70 (m, 1H, 
NH), 5.24 (dd, 1H, J 3.4 and 6.4 Hz, 4-H), 4.90 (dd, 1H, J 
6.4 and 10.9 Hz, 5-H), 4.12 (m, 2H, 2-H + 3-H), 3.87 (s, 
3H, CO2Me), 3.78 (s, 3H, OMe) and 3.32 (m, 1H, OH); δ 
(13C, CDCl3 + 2 drops DMSO): 172.3 (CO), 147.8, 146.3, 
130.2 (Cq), 129.1 (2 x ArCH), 127.9 (ArCH), 127.7 (2 x 
ArCH), 127.4 (2 x ArCH), 127.3 (2 x ArCH), 120.1, 115.9, 
111.2 (ArCH), 104.4 (Cq), 97.5 (C4), 73.1 (C2), 67.6 (C3), 
55.5 (ArOCH3), 53.0 (C5) and 40.7 (OCH3); νmax (KBr): 
3459, 3254, 3008, 2956, 1739, 1601, 1555, 1457, 1438, 
1367, 1204, 1008 816, 759 and 697 cm-1; m/z (ES+): 473 
(M+.+Na+2), 472 (M+.+Na+1), 471 (M+.+Na), 449 (M+.+1, 
100); (ES-): 448 (M+.), 447 (M+.-1, 100); m/z (%, FAB+): 
449 (M+.+1, 100), 315 (50). 
Methyl 5-(1,1'-biphenyl-4-yl)-3-(4-hydroxy-3-
methoxyphenyl)-2-methyl-4-nitro-prolinate (9l) 
Obtained from imine 6e (267 mg, 1 mmol), E-nitrostyrene 
7c (195 mg, 1 mmol), triethylamine (0.21 mL, 1.5 mmol) 
and silver oxide (30 mg, 0.13 mmol) in toluene (20 mL) 
over 18 h. Purification by flash chromatography eluting 
with dichloromethane afforded the product (300 mg, 65%) 
as a pale yellow amorphous solid, m.p. 172-175 °C. Found: 
C, 67.70; H, 5.70; N, 6.35. C26H26N2O6 requires C, 67.50; 
H, 5.70; N, 6.05 %; δ (1H, 300 MHz): 7.62-7.59 (m, 5H, 
ArH), 7.55 (m, 4H, ArH), 6.92 (m, 1H, ArH), 6.78 (m, 2H, 
ArH), 5.69 (t, 1H, J 7.3 Hz, 4-H), 5.12 (d, 1H, J 7.3 Hz, 5-
H), 4.53 (d, 1H, J 7.3 Hz, 3-H), 3.88 (s, 6H, CO2Me and 
OMe), 3.30 (m, 1H, NH) and 1.24 (s, 3H, CH3); δ (13C, 
CDCl3 + 2 drops d6-DMSO): 175.1 (CO), 147.6, 146.5, 
141.5, 140.6, 135.4 (Cq), 129.1 (2 x ArCH), 127.8 (3 x 
ArCH), 127.4 (2 x ArCH), 127.3 (2 x ArCH), 126.8 (Cq), 
120.9, 115.5, 112.8 (ArCH), 104.4 (Cq), 95.6 (C4), 68.8 
(C2), 64.3 (C3), 56.7 (ArOCH3), 56.3 (C5), 53.2 (OCH3) and 
21.9 (CH3); νmax (KBr): 3258, 1736, 1600, 1558, 1437, 
1258, 1137, 853, 760 and 717 cm-1; m/z (%, FAB): 463 
(M+.+1, 100), 315 (95); m/z (ES+): 485 (M+.+Na), 463 
(M+.+1, 100); (ES-): 462 (M+.), 461 (M+.-1, 100). 
N
H
O2N
CO2CH3
OH
OMe
Me45 1
2
3
Methyl 3-(2-furyl)-5-(2-naphthyl)-4-nitro-prolinate (9m) 
Obtained from imine 6a (227 mg, 1 mmol), E-nitrostyrene 
7d (139 mg, 1 mmol), triethylamine (0.21 mL, 1.5 mmol) 
and silver acetate (250 mg, 1.5 mmol) in toluene (20 mL) 
over 15 h. Trituration with ether and filtration afforded the 
product (318 mg, 87%) as pale yellow needles, m.p. 131-
133 °C. Found: C, 65.30; H, 4.90; N, 7.80. C20H18N2O5 
requires C, 65.55; H, 4.95; N, 7.65 %; δ (1H, 300 MHz): 
7.87-7.83 (m, 4H, ArH), 7.54-7.47 (m, 3H, ArH), 7.43 (d, 
1H, J 1.9 Hz, furyl-H’), 6.42 (dd, 1H, J 1.9 and 3.4 Hz, 
furyl-H’), 6.34 (d, 1H, J 3.4 Hz, furyl-H’), 5.46 (dd, 1H, J 
6.0 and 2.6 Hz, 4-H), 5.05 (bs, 1H, 5-H), 4.38 (dd, 1H, J 
6.8 and 2.6 Hz, 3-H), 4.29 (bd, 1H, J 6.0 Hz, 2-H), 3.90 (s, 
3H, OMe) and 3.48 (bs, 1H, NH); δ (13C, CDCl3 + 2 drops 
d6-DMSO): 171.4 (CO), 150.7 (furan C2'), 143.0 (furan C5') 
133.1, 133.0 (Cq), 128.2, 128.1, 127.6 (ArCH), 126.5 (2 x 
ArCH), 125.6, 124.5 (ArCH), 110.8, 107.9 (furan C3', C4'), 
93.9 (C4), 67.1 (C2), 64.3 (C3), 52.7 (C5) and 48.2 (OCH3); 
νmax (KBr) 3302, 1743, 1541, 1436, 1127, 863, 812 and 747 
 % Enhancement 
Irradiated 
proton 
H-3 H-4 H-5 Phenyl Naph- CH3
H-3  4.2 - 10.7 1.3, 1.4 11.8 
H-4 1.9  4.8 7.9 2.8, 2.4 - 
H-5 - 8.2  3.0 5.3, 4.8 3.3 
CH3 0.4 0.8 2.0 1.8 - - 
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cm-1; m/z (ES+) 390 (M+.+1+Na), 389 (M+.+ Na, 100), 367 
(M+.+1); m/z (%, FAB): 367 (M+.+1, 100), 233 (55). 
Methyl 3-(2-furyl)-2-methyl-5-(2-naphthyl)-4-nitro-
prolinate (9n) Obtained from imine 6b (241 mg, 1 mmol), 
E-nitrostyrene 7d (139 mg, 1 mmol), triethylamine (0.21 
mL, 1.5 mmol) and silver acetate (250 mg, 1.5 mmol) in 
toluene (20 mL) over 18 h. Trituration with ether and 
filtration afforded the product (304 mg, 80%) as a 
colourless solid, m.p. 110-112 °C. Found: C, 66.20; H, 
5.25; N, 7.35. C21H20N2O5 requires C, 66.30; H, 5.30; N, 
7.35 %; δ (1H, 250 MHz): 7.87-7.80 (m, 4H, ArH), 7.52-
7.41 (m, 4H, ArH), 6.39 (dd, 1H, J 2.0 and 3.2 Hz, furyl-
H), 6.31 (d, 1H, J 3.2 Hz, furyl-H), 5.69 (dd, 1H, J 4.5 and 
6.8 Hz, 4-H), 5.28 (dd, 1H, J 6.8 and 10.1 Hz, 5-H), 4.64 
(d, 1H, J 4.5 Hz, 3-H), 3.92 (s, 3H, OMe), 3.54 (d, 1H, J 
10.1 Hz, NH) and 1.29 (s, 3H, CH3); δ (13C): 175.0 (CO), 
150.1 (furan C2'), 143.1 (furan C5') 133.8, 133.5 (Cq), 128.9, 
128.6, 128.1, 126.9, 126.8, 126.4, 124.8 (ArCH), 111.2, 
109.7 (furan C3', C4'), 94.2 (C4), 69.9 (C2), 65.8 (C3), 53.5 
(C5), 51.5 (OCH3) and 22.5 (CH3); νmax (KBr): 3361, 2998, 
2949, 1734, 1552, 1436, 1148, 1014, 863, 772 and 752 cm-
1; m/z (%): 379 (M+.-1, 10), 363 (25), 333 (40); m/z (ES): 
404 (M+.+1+Na), 403 (M+.+Na), 381 (M+.+1, 100). 
nOe data for 9n: 
 
Methyl 2-benzyl-3-(2-furyl)-5-(2-naphthyl)-4-nitro-
prolinate (9o) Obtained from imine 6c (377 mg, 1 mmol), 
E-nitrostyrene 7d (139 mg, 1 mmol), triethylamine (0.21 
mL, 1.5 mmol) and silver acetate (250 mg, 1.5 mmol) in 
toluene (20 mL) over 16 h. Trituration with ether and 
filtration afforded the product (355 mg, 78%) as a pale 
orange amorphous solid, m.p. 151-154°C. Found: C, 70.80; 
H, 5.30; N, 6.05. C27H24N2O5 requires C, 71.05; H, 5.30; N, 
6.15 %; δ (1H, 300 MHz): 7.92 (bs, 1H, ArH), 7.87-7.79 
(m, 4H, ArH), 7.53-7.47 (m, 4H, ArH), 7.25-7.14 (m, 5H, 
ArH), 6.48-6.44 (m, 2H, furyl-H’), 5.63 (dd, 1H, J 3.8 and 
6.4 Hz, 4-H), 5.34 (bt, 1H, J 7.7 Hz, 5-H), 4.55 (d, 1H, J 
3.8 Hz, 3-H), 3.79 (s, 3H, OMe), 3.48 (bd, 1H, J 9.4 Hz, 
NH), 2.78 (AB, d, J 13.6 Hz, 1H, CHH) and 2.63 (AB, d, J 
13.6 Hz, 1H, CHH) ; δ (13C): 173.9 (CO), 149.9 (furan C2'), 
136.8, 133.8, 133.6, 132.7 (Cq), 130.4 (2 x ArCH), 128.6 
(ArCH), 128.5 (2 x ArCH), 128.1, 127.4, 126.9, 126.8, 
126.4, 124.9 (ArCH), 111.3, 110.5 (furan C3', C4'), 94.4 
(C4), 74.4 (C2), 66.1 (C3), 53.0 (C5), 52.3 (OCH3) and 40.8 
(CH2); νmax (film): 3328, 3122, 3056, 2951, 1740, 1602, 
1542, 1455, 1429, 1195, 900, 868, 750 and 701 cm-1; m/z 
(ES+): 457 (M+.+1, 100). 
Methyl 5-(1,1'-biphenyl-4-yl)-3-(2-furyl)-4-nitro-
prolinate (9p) Obtained from imine 6d (253 mg, 1 mmol), 
E-nitrostyrene 7d (139 mg, 1 mmol), triethylamine (0.21 
mL, 1.5 mmol) and silver acetate (250 mg, 1.5 mmol) in 
toluene (20 mL) over 22 h. Purification by flash 
chromatography eluting with 19:1 v/v dichloromethane/ 
hexane afforded the product (384 mg, 98%) as a colourless 
powder, m.p. 144-148 °C. Found: C, 67.30; H, 5.15; N, 
7.20. C22H20N2O5 requires C, 67.35; H, 5.15; N, 7.15 %. δ 
(1H, 250 MHz): 7.61-7.51 (m, 4H, ArH), 7.48-7.30 (m, 6H, 
ArCH), 6.39 (dd, 1H, J 1.9 and 3.6 Hz, furyl-H’), 6.31 (dd, 
1H, J 0.5 and 3.6 Hz, furyl-H), 5.38 (dd, 1H, J 2.6 and 6.2 
Hz, 4-H), 4.91 (dd, 1H, J 6.4 and 11.4 Hz, 5-H), 4.33 (dd, 
1H, J 2.6 and 7.0 Hz, 3-H), 4.25 (dd, 1H, J 7.0 and 9.3 Hz, 
2-H), 3.86 (s, 3H, OMe) and 3.37 (dd, 1H, J 9.3 and 11.4 
Hz, NH); δ (13C, 250 MHz): 171.8 (CO), 151.2 (furyl C2'), 
143.4 (furyl C5'), 142.0, 140.7, 133.3 (Cq), 129.2 (2 x 
ArCH), 128.0 (ArCH), 127.9, 127.5, 127.3 (2 x ArCH), 
111.2, 108.4 (furyl C3'+C4'), 94.4 (C4), 67.9 (C2), 65.2 (C3), 
53.3 (C5) and 49.3 (OCH3); νmax (NaCl): 3375, 3030, 2952, 
1742, 1551, 1437, 1214, 1008, 840, 766 and 699 cm-1; m/z 
(%): 393 (M+.+1, 100). 
N
H
O2N
CO2CH3
Me
O
4
5 1
2
3
Methyl 5-(2-naphthyl)-4-nitro-3-thien-2-yl-prolinate 
(endo-9q and exo-10q) Obtained from imine 6a (227 mg, 1 
mmol), E-nitrostyrene 7e (155 mg, 1 mmol), triethylamine 
(0.21 mL, 1.5 mmol) and silver acetate (250 mg, 1.5 mmol) 
in toluene (20 mL) over 16 h. Trituration with ether and 
filtration afforded the product (343 mg, 90%)(3:1 mixture 
of endo-9q and exo-10q) as colourless plates, m.p. 124-130 
°C. Found: C, 62.70; H, 4.80; N, 7.30; S, 8.40. 
C20H18N2O4S requires C, 62.80; H, 4.75; N, 7.30; S, 8.40 
%; NMR for both isomers were assigned from the 3:1 
mixture. 
 δA (1H, 300 MHz) for endo-9q: 7.85-7.80 (m, 4H, ArH), 
7.60-7.55 (m, 4H, ArH), 7.03 (m, 2H, thienyl-H), 5.38 (dd, 
1H, J 3.1 and 6.2 Hz, 4-H), 5.06 (d, 1H, J 6.2 Hz, 5-H), 
4.59 (dd, 1H, J 3.1 and 7.1 Hz, 3-H), 4.26 (d, 1H, J 7.1 Hz, 
2-H) and 3.88 (s, 3H, OMe); δA (13C): 171.7 (CO), 141.6, 
133.7, 133.5, 131.7 (Cq), 129.0, 128.6, 128.1, 128.0, 127.0, 
126.9, 126.3, 126.1, 125.8, 124.5, (ArCH), 97.2 (C4), 68.5 
(C2), 67.8 (C3), 53.3 (C5) and 50.9 (OCH3);  
δB ( H, 300 MHz) for exo-10q: 8.06-7.84 (m, 4H, ArH), 
7.69-7.48 (m, 3H, ArH), 7.23 (dd, 1H, J 1.6, 4.9Hz, thienyl-
H
 % Enhancement 
Irradiated proton H-3 H-4 H-5 Furyl Naph- 
H-3  2.9 - 5.5 - 
H-4 4.5  7.4 2.0 - 
H-5  13.5  6.2 6.7 
CH3 1.5 0.8 2.1 - - 
B
1
'), 6.97 (m, 2H, thienyl-H), 5.24 (dd, 1H, J 6.5 and 7.6 Hz, 
4-H), 4.87 (d, 1H, J 7.6 Hz, 5-H), 4.69 (dd, 1H, J 6.5 and 
8.1 Hz, 3-H), 4.55 (d, 1H, J 8.1 Hz, 2-H) and 3.50 (s, 3H, 
OMe); δBB (13C): 171.6 (CO), 138.3, 135.3, 133.8 (Cq), 
129.6, 128.2, 127.4, 126.8, 124.5, (ArCH), 96.7 (C4), 68.2 
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(C2), 64.9 (C3), 52.6 (C5) and 49.4 (OCH3); νmax (KBr): 
3365, 3322, 2950, 1740, 1546, 1436, 1203, 832, 751 and 
709 cm-1; m/z (%, FAB) 383 (M+., 100); m/z (ES+): 406 
(M+ +1+Na, 22), 405 (M+.+Na, 100), 383 (M+.+1, 48). 
Methyl 2-methyl-5-(2-naphthyl)-4-nitro-3-thien-2-yl-
prolinate (9r) Obtained from imine 6b (241 mg, 1 mmol), 
E-nitrostyrene 7e (155 mg, 1 mmol), triethylamine (0.21 
mL, 1.5 mmol) and silver oxide (30 mg, 0.13 mmol) in 
toluene (20 mL) over 16 h. The crude material was washed 
with ether and filtered to afford the product (360 mg, 91%) 
as pale brown prisms, m.p. 156-158 °C. Found: C, 63.50; 
H, 5.00; N, 7.10; S, 8.20. C21H20N2O4S requires C, 63.60; 
H, 5.10; N, 7.05; S, 8.10 %; δ (1H, 250 MHz): 7.88-7.80 
(m, 4H, ArH), 7.53-7.45 (m, 3H, ArH), 7.29-7.27 (m, 1H, 
thienyl-H), 7.02 (m, 2H, thienyl-H), 5.68 (t, 1H, J 7.0 Hz, 
4-H), 5.24 (t, 1H, J 9.0 Hz, 5-H), 4.93 (d, 1H, J 6.8 Hz, 3-
H), 3.95 (s, 3H, OMe), 3.35 (d, 1H, J 9.4 Hz NH) and 1.34 
(s, 3H, CH3); δ(13C): 174.7 (CO), 138.2, 133.8, 133.5, 
133.2 (Cq), 128.8, 128.6, 128.1, 127.5, 127.1, 126.9, 126.8, 
126.7 125.7, 124.9, (ArCH), 96.3 (C4), 68.8 (C2), 64.4 (C3), 
53.4 (C5), 52.3 (OCH3) and 22.2 (CH3); νmax (KBr): 3355, 
2997, 2947, 1747, 1553, 1435, 1147, 822, 752 and 713 cm-
1; m/z (%, FAB): 397 (M+.+1, 85); m/z (ES+): 420 (M+ 
+1+Na), 419 (M+.+Na), 397 (M+.+1, 71). 
nOe data for 9r: 
 
Methyl 2-benzyl-5-(2-naphthyl)-4-nitro-3-thien-2-yl-
prolinate (9s) Obtained from imine 6c (317 mg, 1 mmol), 
E-nitrostyrene 7e (155 mg, 1 mmol), triethylamine (0.21 
mL, 1.5 mmol) and silver oxide (30 mg, 0.13 mmol) in 
toluene (20 mL) over 17 h. Purification was achieved by 
triturating the residue with ether and filtration to afford the 
product (330 mg, 70%) as a pale brown amorphous solid, 
m.p. 158-161 °C. Found: C, 68.35; H, 5.15; N, 6.10; S, 
7.00. C27H24N2O4S requires C, 68.65; H, 5.10; N, 5.95; S, 
6.80 %; δ (1H, 250 MHz): 7.93 (bs, 1H, ArH), 7.87-7.00 
(m, 14H, ArH), 5.72 (dd, 1H, J 5.5 and 7.3 Hz, 4-H), 5.38 
(bs, 1H, 5-H), 4.87 (d, 1H, J 5.5 Hz, 3-H), 3.81 (s, 3H, 
OMe), 3.39 (bs, 1H, NH) and 2.83 (s, 2H, CH2); δ (13C): 
173.9 (CO), 137.9, 136.6, 133.8, 133.5, 133.1 (Cq), 130.4 
(2 x ArCH), 128.9 (ArCH), 128.6 (3 x ArCH), 128.1, 
128.0, 127.6, 127.5, 127.0, 126.9, 126.7, 126.0, 124.9 
(ArCH), 97.1 (C4), 73.1 (C2), 64.9 (C3), 53.4 (C5), 53.0 
(OCH3) and 40.9 (CH2); νmax (KBr) 3330, 3118, 3094, 
3055, 2948, 1743, 1543, 1453, 1428, 1194, 954, 902, 867, 
749 and 702 cm-1; m/z (ES+): 496 (M+ +1+Na), 495 
(M+.+Na), 473 (M+.+1, 100); (ES-): 471 (M+.-1, 100).m/z 
(FAB+): 495 (M+.+Na, 10), 473 (M+.+ 1, 100). 
Methyl 5-(1,1'-biphenyl-4-yl)-4-nitro-3-thien-2-yl-
prolinate (9t) Obtained from imine 6d (253 mg, 1 mmol), 
E-nitrostyrene 7e (155 mg, 1 mmol), triethylamine (0.21 
mL, 1.5 mmol) and silver acetate (250 mg, 1.5 mmol) in 
toluene (20 mL) over 16 h. Purification was achieved by 
dissolving the residue in toluene and adding ether dropwise 
which afforded the product (285 mg, 70%) as colourless 
needles, m.p.   162-164 °C. Found: C, 64.65; H, 5.05; N, 
6.85; S, 7.85. C22H20N2O4S requires C, 64.70; H, 4.95; N, 
6.85; S, 7.85 %; δ (1H, 300 MHz): 7.60-7.48 (m, 5H, ArH), 
7.43-7.24 (m, 5H, ArH and thienyl-H), 6.31 (dd, 1H, J 2.3 
and 3.0 Hz, thienyl-H), 6.23 (d, 1H, J 3.0 Hz, thienyl-H), 
5.30 (dd, 1H, J 3.0 and 6.0 Hz, 4-H), 4.83 (bd, 1H, J 6.0 
Hz, 5-H), 4.25 (dd, 1H, J 3.0 and 6.8 Hz, 3-H), 4.15 (d, 1H, 
J 6.8 Hz, 2-H), and 3.79 (s, 3H, OMe); δ (13C): 171.5 (CO), 
151.0 (C2’), 143.2 (ArCH), 141.8, 140.5, 133.0 (Cq), 129.0 
(2 x ArCH), 127.7 (ArCH), 127.6 (2 x ArCH), 127.3 (2 x 
ArCH), 127.0 (2 x ArCH), 111.0, 108.1 (thienyl CH), 94.2 
(C4), 67.6 (C3) 65.0 (C5), 53.0 (C2) and 49.1 (OCH3); νmax 
(KBr): 3303, 3031, 2998, 2958, 1744, 1547, 1435, 1211, 
1012, 830, 761 and 696 cm-1; m/z (ES+): 431 (M+.+Na), 
393 (M+.-15, 100), 375 (M+.-33). N
H
O2N
CO2CH3
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Methyl 5-(2-naphthyl)-4-nitro-3-pyridin-3-yl-prolinate 
(9u) Obtained from imine 6a (227 mg, 1 mmol), E-
nitrostyrene 7f (150 mg, 1 mmol), triethylamine (0.21 mL, 
1.5 mmol) and silver oxide (30 mg, 0.13 mmol) in toluene 
(20 mL) over 16 h. Purification was achieved by washing 
with ether and filtering off the product (150 mg, 40%) as 
pale yellow plates, m.p. 159-162 °C. Found: C, 66.95; H, 
5.20; N, 11.30. C21H19N3O4 requires C, 66.85; H, 5.05; N, 
11.15 %; δ (1H, 300 MHz, CDCl3 + 2 drops d6-DMSO): 
8.39 (bd, 1H, J 1.9 Hz, pyridyl-H), 8.34 (dd, 1H, J 1.9 and 
4.7 Hz, pyridyl-H), 7.66 (bs, 1H, ArH), 7.62-7.56 (m, 3H, 
ArH), 7.52 (dt, 1H, J 1.9 and 7.9 Hz, pyridyl-H), 7.27-7.23 
(m, 3H, ArH), 7.13 (dd, 1H, J 4.7 and 7.9 Hz, pyridyl-H), 
5.28 (dd, 1H, J 4.7 and 7.3 Hz, 4-H), 4.94 (dd, 1H, J 7.3 
and 9.4 Hz, 5-H), 4.06 (dd, 2H, J 4.7 and 8.3 Hz, 3-H), 3.93 
(t, 1H, J 8.3 Hz, 2-H), 3.57 (s, 3H, OMe) and 3.29 (bt, 1H, 
J 9.4 Hz, NH); δ (13C, CDCl3 +2 drops d6-DMSO): 171.6 
(CO), 149.8, 149.6 (pyridyl C2', C6'), 135.5 (pyridyl CH), 
134.3, 133.5, 133.3 (Cq), 128.7, 128.4, 128.0 (ArCH), 
126.8 (2 x ArCH), 126.2, 124.7, 124.3, (ArCH), 96.4 (C4), 
67.6 (C2), 67.2 (C3), 53.1, (C5) and 52.4 (OCH3); νmax 
(KBr): 3276, 3024, 2959, 1746, 1544, 1432, 1213, 832, 750 
and 719 cm-1; m/z (%, FAB): 378 (M+.+1, 80); m/z (ES+): 
401 (M+ +1+Na), 400 (M+.+Na), 378 (M+.+1, 100); (ES-): 
377 (M+.) 376 (M+.-1, 100). 
Methyl 2-methyl-5-(2-naphthyl)-4-nitro-3-pyridin-3-yl-
prolinate (9v) Obtained from imine 6b (241 mg, 1 mmol), 
 % Enhancement 
Irradiated proton H-3 H-4 H-5 Thiophe- Naph- 
H-3  1.9 - 3.0 1.5, 1.3 
H-4 2.5  7.8 4.5 - 
H-5 - 9.8  0.8 4.6, 4.7 
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E-nitrostyrene 7f (150 mg, 1 mmol), triethylamine (0.21 
mL, 1.5 mmol) and silver acetate (250 mg, 1.5 mmol) in 
toluene (20 mL) over 18 h. Purification was achieved using 
a SPE-Anachem SI Mega Bond-Elut (20 g). Eluting with 
100% hexane to 100% ethyl acetate gradient elution 
afforded the product (305 mg, 78 %) as a colourless 
powder, m.p. 127-129 °C. Found: C, 67.50; H, 5.35; N, 
10.55. C22H21N3O4 requires C, 67.50; H, 5.40; N, 10.75 %; δ (1H, 300 MHz): 8.63 (bs, 1H, pyridyl-H), 8.61 (dd, 1H, J 
1.7 and 4.5 Hz, pyridyl-H), 7.92 (bs, 1H, ArH), 7.86 (m, 
3H, ArH), 7.68 (dt, 1H, J 1.7 and 7.9 Hz, pyridyl-H), 7.51 
(m, 3H, ArH), 7.38 (dd, 1H, J 4.5 and 7.9 Hz, ArH), 5.75 
(dd, 1H, J 6.6 and 7.3 Hz, 4-H), 5.28 (d, 1H, J 7.3 Hz, 5-H), 
4.64 (d, 1H, J 6.6 Hz, 3-H), 3.93 (s, 3H, OMe), 3.50 (bs, 
1H, NH) and 1.29 (s, 3H, CH3); δ (13C): 174.6 (CO), 150.4, 
149.9 (pyridyl C2', C6'), 136.4 (ArCH), 133.8, 133.5, 132.9, 
131.8 (Cq), 128.9, 128.6, 128.1, 126.93, 126.86, 126.7, 
124.8, 123.9 (ArCH), 95.2 (C4), 68.8 (C2), 65.1 (C3), 54.6 
(C5), 53.5 (OCH3) and 22.8 (CH3); νmax (KBr) 3367, 3322, 
3024, 2947, 1757, 1741, 1547, 1430, 1136, 819, 757 and 
715 cm-1; m/z (ES): 414 (M+.+Na), 393 (M+.+2), 392 
(M+.+1, 100); (ES-): 392, 391 (M+.), 390(M+.-1, 100). 
3-Nitro-2,4-diphenyl-7-oxa-1-azaspiro[4.4]nonan-6-one 
(14a and 15a) Obtained from imine 12a (200 mg, 1.05 
mmol), E-nitrostyrene (0.16 g, 1.05 mmol), triethylamine 
(0.16 mL, 1.55 mmol) and silver acetate (0.26 g, 1.6 mmol) 
in acetonitrile (10 mL) over 4 h. Purification by flash 
chromatography eluting with 4:1 v/v ether:hexane afforded 
first 15a (70 mg, 20%), followed by 14a (0.19 g, 54%) as 
colourless solids.  
Cycloadduct 14a. Crystallised from dichloromethane 
/hexane as colourless plates, m.p. 144 -146 °C. Found: C, 
67.20; H, 5.40; N, 8.10. C19H18O4N2 requires: C, 67.40; H, 
5.40; N, 8.30 %; δ (1H, 500 MHz): 7.42-7.26 (m, 10H, Ar-
H), 5.79 (t, 1H, J 8.0 Hz, 3-H), 4.92 (dd, 1H, J 8.0 and 10.9 
Hz, 2-H), 4.65 (d, 1H, J 8.0 Hz, 4-H), 4.18 (ddd, 1H, J 5.3, 
8.0 and 8.9 Hz, 8-CH2), 3.32 (dd, 1H, J 7.3 and 8.9 Hz, 8-
CH2), 3.19 (d, 1H, J 10.9 Hz, NH) and 2.28-2.18 (m, 2H, 9-
CH2); νmax (film): 1768, 1552, 1497, 1456, 1370, 1219, 
1181, 1146, 1125 and 1053 cm-1; m/z (%): 339(M++1, 0.4), 
328(2.2), 248(54), 247(53), 232(86), 189(43), 149(60), 
77(92) and 57(100). 
 
 
 
 
 
nOe data for 14a: 
 
Cycloadduct 15a. Crystallised from 
dichloromethane/hexane as colourless plates, m.p. 174-176 
°C. Found: C, 67.35; H, 5.50; N, 8.30. C19H18O4N2 
requires: C, 67.40; H, 5.40; N, 8.30 %; δ (1H, 500MHz), 
7.65 (d, 2H, J 7.4 Hz, Ar-H), 7.41-7.26 (m, 8H, Ar-H), 5.76 
(t, 1H, J 8.3 Hz, 3-H), 5.28 (d, 1H, J 8.3 Hz, 2-H), 4.28 
(ddd, 1H, J 4.2, 6.8 and 9.3 Hz, 8-CH2), 4.12-4.08 (m, 2H, 
8-CH2 and 4-H), 2.44 (b, 1H, NH), 2.36 (dt, 1H, J 6.8 and 
13.6 Hz, 9-CH2) and 2.27 (dt, 1H, J 6.8 and 10.3 Hz, 9-
CH2); νmax (film): 1762, 1547, 1496, 1456, 1372, 1219, 
1182 and 1022 cm-1; m/z (%): 339(M+ +1, 0.3), 292 (26), 
248(66), 232(88), 193(100) and 115(89). 
 
 
nOe data for 15a: 
 
 
 
 % Enhancement 
Irradiated proton H-4 H-3 H-2 NH 8-CH2 ArH 
H-4  - - 2.0 - 7.3 
H-3 1.0  6.8 - - 8.5 
H-2 - 6.7  1.0 3.8 5.6 
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 % Enhancement 
Irradiated proton H-4 H-3 H-2 ArH 
H-4  4.7 - 4.2 
H-3 8.5  - 4.8 
H-2 - 1.6  15.0 
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3-Nitro-4-phenyl-2-pyridin-3-yl-7-oxa-1-
azaspiro[4.4]nonan-6-one (14b) Obtained from imine 12b 
(200 mg, 1.05 mmol), E-nitrostyrene (0.16 g, 1.05 mmol), 
triethylamine (0.16 mL, 1.55 mmol) and silver acetate (0.26 
g, 1.6 mmol) in acetonitrile (10 mL) over 4 h. Purification 
by flash chromatography eluting with ethyl acetate afforded 
the cycloadduct 14b (144 mg, 40%) as a colourless solid 
together with small amount of epimerised cycloadduct. 
Product 14b crystallised from dichloromethane/hexane as 
colourless needles, m.p. 170-172 °C. Found: C, 63.45; H, 
5.00; N, 12.55. C18H17O4N3 requires: C, 63.71; H, 5.05; N, 
12.38 %; δ (1H, 250 MHz): 8.63 (m, 2H, pyridyl-H), 7.9 
(m, 1H, pyridyl-H), 7.45-7.26 (m, 6H, pyridyl-H and Ar-
H), 5.82 (t, 1H, J 8.3 Hz, 3-H), 4.96 (dd, 1H, J 8.3 and 10.2 
Hz, 2-H), 4.65 (d, 1H, J 8.3 Hz, 4-H), 4.17 (dd, 1H, J 5.0 
and 8.6 Hz, 8-CH2), 3.28 (dd, 1H, J 7.4 and 8.6 Hz, 8-CH2), 
3.08 (d, 1H, J 10.2 Hz, NH) and 2.36-2.15 (m, 2H, 9-CH2); 
νmax (film): 1769, 1552, 1372, 1218, 1183 and 1024 cm-1; 
m/z (%): 340 (M+ +1, 7), 293(12), 249(59), 233(91), 
194(100) and 115(21). 
 
nOe data for 14b: 
 
 
3-Nitro-4-phenyl-2-N-sulphonylindol-3-yl-7-oxa-1-
azaspiro[4.4]nonan-6-one (14c and 15c) Obtained from 
imine 12c (200 mg, 0.54 mmol), E-nitrostyrene (0.08 mg, 
0.54 mmol), triethylamine (0.08 mL, 0.6 mmol) and silver 
acetate (0.14 g, 0.59 mmol) in acetonitrile (20 mL) over 24 
h. Purification by flash chromatography eluting with 9:1 
v/v ether:hexane afforded first 15c (191 mg, 68%) followed 
by 14c (42 mg, 15%). 
Cycloadduct 14c Crystallised from 
dichloromethane/hexane as colourless needles, m.p. 138-
140 °C. Found (HRMS, M++H): 518.1388. C27H23O6N3S 
requires: 518.1386; δ (1H, 250 MHz): 7.97-7.24 (m, 10H, 
ArH), 5.83 (t, 1H, J 7.5 Hz, 3-H), 5.12 (dd, 1H, J 7.5 and 
11.0 Hz, 2-H), 4.68 (d, 1H, J 7.5 Hz, 4-H), 4.19 (ddd, 1H, J 
5.9, 7.6 and 11.3 Hz, 8-CH2), 3.36 (dd, 1H, J 7.2 and 11.3 
Hz, 8-CH2), 3.21 (d, 1H, J 11.0 Hz, NH) and 2.28-2.21(m, 
2H, 9-CH2); νmax (film): 1769, 1552, 1448, 1368, 1216 and 
1175 cm-1; m/z (%): 517(1.3), 471(6), 427(9), 368(54), 
285(11), 271(8), 227(28) and 77(100). 
Cycloadduct 15c Crystallised from 
dichloromethane/hexanae as colourless plates, m.p. 157-
159 °C. Found (HRMS, M++H): 518.1390. C27H23O6N3S 
requires: 518.1386; δ (1H, 250 MHz): 7.98-7.23 (m, 10H, 
ArH), 5.73 (t, 1H, J 6.4 Hz, 3-H), 5.47 (d, 1H, J 6.4 Hz, 2-
H), 4.34 (m, 1H, 8-CH2), 4.16-4.07 (m, 2H, 8-CH2 and 4-
H), 2.66 (b, 1H, NH) and 2.48-2.32 (m, 2H, 9-CH2); νmax 
(film): 1766, 1549, 1448, 1371, 1175 and 1125 cm-1; m/z 
(%): 517(M+, 1.5), 427(28), 368(24), 329(6), 285(38), 
230(41) and 77(100). 
2-Cyclohexyl-3-nitro-4-phenyl-7-oxa-1-
azaspiro[4.4]nonan-6-one (14d) Obtained from imine 12d 
(1 g, 5.11 mmol), E-nitrostyrene (0.76 g, 5.11 mmol), 
triethylamine (0.8 mL, 5.62 mmol) and silver oxide (0.12 g, 
0.5 mmol) in toluene (50 mL) over 1 h. Purification by 
flash chromatography eluting with 1:1 v/v ether:hexane 
afforded the product (1.32 g, 74%) which crystallised from 
dichloromethane/hexane as colourless plates, m.p. 159-161 
°C. Found: C, 66.25; H, 7.15; N, 8.40. C19H24O4N2 
requires: C, 66.25; H, 7.00; N, 8.15%; δ (1H, 250 MHz): 
7.57-7.12 (m, 5H, Ar-H), 5.51 (dd, 1H, J 4.7 and 5.9 Hz, 3-
H), 4.40 (d, 1H, J 4.7 Hz, 4-H), 4.16 (dt, 1H, J 6.8 and 8.7 
Hz, 8-CH2), 3.45 (m, 1H, 8-CH2), 3.19 (m, 1H, 2-H), 2.79 
(d, 1H, J 14.1 Hz, NH), 2.05-1.99 (m, 3H, 9-CH2 and 
cyclohexyl-H) and 1.89-1.21 (m, 10H, cyclohexyl-H); νmax 
(film): 2925, 2853, 1769, 1546, 1452, 1369, 1218 and 1175 
cm-1; m/z (%): 345 (M+ +1, 0.7), 298(16), 254(76), 
199(91), 170(73), 156(77), 143(40) and 117(100). 
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2-Cyclohex-3-en-1-yl-3-nitro-4-phenyl-7-oxa-1-
azaspiro[4.4]nonan-6-one (14e) Obtained from imine 12e 
(400 mg, 2.06 mmol), E-nitrostyrene (0.31 g, 2.06 mmol), 
triethylamine (0.3 mL, 2.26 mmol) and silver oxide (47 mg, 
0.2 mmol) in toluene (30 mL) over 1 h. Purification by 
flash chromatography eluting with ether afforded the 
product (0.36 g, 51%) as a 1:1 mixture of diastereomers 
which crystallised from dichloromethane/hexane as 
colourless plates, m.p. 134-142 °C. Found: C, 66.45; H, 
6.50; N, 8.00. C19H22O4N2 requires: C, 66.65; H, 6.50; N, 
8.20 %; δ (1H, 250 MHz): 7.38-7.14 (m, 5H, Ar-H), 5.68-
5.48 (m, 3H, olefinic-H and 3-H), 4.44 and 4.43 (d, 1H, J 
4.5 Hz, 4-H), 4.16 (m, 1H, 8-CH2), 3.49-3.30 (m, 2H, 8-
CH2 and 2-H), 2.86 and 2.80 (d, 1H, J 6.4 Hz, NH) and 
2.27-1.59 (m, 9H, 9-CH2 and cyclohexenyl-H); νmax (film): 
2918, 1769, 1733, 1653, 1546, 1506, 1496, 1437, 1317 and 
1271 cm-1; m/z (%): 342(M+, 0.4), 325(0.6), 252(90), 
215(23), 197(64), 170(71), 156(93), 143(73) and 117(100). 
2-(2,6-Dimethyl-5-heptenyl)-3-nitro-4-phenyl-7-oxa-1-
azaspiro[4.4]nonan-6-one (14f) Obtained from imine 12f 
 % Enhancement 
Irradiated proton H-4 H-3 H-2 NH ArH 
H-4  - - 1.8 12.0 
H-3 -  7.7 - 13.4 
H-2 - 8.4  1.7 7.9 
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(700 mg, 2.95 mmol), E-nitrostyrene (0.44 g, 2.95 mmol), 
triethylamine (0.5 mL, 3.24 mmol) and silver oxide (68 mg, 
0.3 mmol) in toluene (30 mL) over 4 h. Purification by 
flash chromatography eluting with 1:1 v/v ether:hexane 
afforded the product (0.44 g, 42%) as a pale yellow oil 
which comprised a 1:1 mixture of diastereomers. Found: C, 
68.50; H, 7.90; N, 7.10. C19H22O4N2 requires: C, 68.40; H, 
7.80; N, 7.25 %; δ (1H, 250 MHz): 7.41-7.16 (m, 5H, Ar-
H), 5.48 (m, 1H, 3-H), 5.06 (m, 1H, olefinic-H), 4.49 (m, 
1H, 4-H), 4.16 (m, 1H, 8-CH2), 3.65 (m, 1H, 2-H), 3.35 (m, 
1H, 8-CH2), 2.50 (b, 1H, NH), 2.12-1.91 (m, 4H, 9-CH2 
and citronellyl-H), 1.69 and 1.60 (2 x s, 2 x 3H, Me2C=C) 
and 1.58-1.14 (m, 3H, citronellyl-CH3); νmax (film): 2954, 
2916, 1770, 1549, 1373, 1219, 1180 and 1023 cm-1; m/z 
(%): 386(M+, 1.2), 340(16), 312(21), 296(100), 282(20), 
256(6), 241(9), 210(12), 184(41), 170(83) and 156(96). 
2-(8,8-Dimethyl-1,2,3,4,5,6,7,8-octahydro-2-
naphthalenyl)-3-nitro-4-phenyl-7-oxa-1-
azaspiro[4.4]nonan-6-one (14g) Obtained from imine 12g 
(1.0 g, 3.6 mmol), E-nitrostyrene (0.53 g, 3.6 mmol), 
triethylamine (0.55 mL, 3.9 mmol) and silver oxide (0.08 g, 
0.36 mmol) in toluene (40 mL) over 3 h. Purification by 
flash chromatography eluting with 1:1 v/v ether:hexane 
afforded the product (0.89 g, 58%) as a 1:1 mixture of 
diastereomers which crystallised from dichloromethane/ 
hexane as colourless plates, m.p. 165-172 °C. Found: C, 
71.00; H, 7.65; N, 6.35. C25H32O4N2 requires: C, 70.75; H, 
7.60; N, 6.60 %; δ (1H, 250 MHz): 7.38-7.35 (m, 3H, Ar-
H), 7.16-7.14 (m, 2H, Ar-H), 5.53 (m, 1H, 3-H), 4.45 (m, 
1H, 4-H), 4.18 and 3.46 (2 x m, 2 x 1H, 8-CH2), 3.43 (m, 
1H, 2-H), 2.84 (b, 1H, NH), 2.06-1.43 (m, 15H, 9-CH2 and 
aliphatic-H), 1.02 and 0.95 (2 x s, 2 x 3H, CH3); νmax (film): 
2924, 1771, 1547, 1369, 1219, 1176 and 1023 cm-1; m/z 
(%): 424(M+, 1.5), 407(5), 378(10), 334(25), 216(62), 
143(80), 117(80) and 91(100). 
2-[3-(4-Methyl-3-pentenyl)-3-cyclohexen-1-yl]-3-nitro-4-
phenyl-7-oxa-1-azaspiro[4.4]nonan-6-one (14h) Obtained 
from imine 12h (1.5 g, 5.4 mmol), E-nitrostyrene (0.81 g, 
5.4 mmol), triethylamine (0.83 mL, 5.9 mmol) and silver 
oxide (0.12 g, 0.54 mmol) in toluene (40 mL) over 4 h. 
Purification by flash chromatography eluting with 1:1 v/v 
ether:hexane afforded the product (1.96g, 85%) as a 1:1 
mixture of diastereomers which crystallised from 
dichloromethane/hexane as colourless plates, m.p. 94-102 
°C. Found: C, 70.75; H, 7.60; N, 6.60. C25H32O4N2 
requires: C, 70.75; H, 7.60; N, 6.60 %; δ (1H, 250 MHz): 
7.38-7.33 (m, 3H, Ar-H), 7.17-7.14 (m, 2H, Ar-H), 5.58 
and 5.51 (dd, 1H, J 4.5 and 5.9 Hz, 3-H), 5.36 (b, 1H, 
olefinic-H), 4.45 and 4.42 (d, 1H, J 4.5 Hz, 4-H), 4.17 (ddd, 
1H, J 1.9, 6.7 and 8.7 Hz, 8-CH2), 3.44 (m, 1H, 8-CH2), 
3.34 (m, 1H, 2-H), 2.84 (b, 1H, NH), 2.25 (m, 1H, 
aliphatic-H), 2.06-1.98 (m, 11H, 9-CH2 and aliphatic-H), 
1.69 and 1.61 (2 x s, 2 x 3H, 2 x CH3) and 1.43 (m, 1H, 
aliphatic-H); νmax (film): 2917, 1771, 1547, 1369, 1219, 
1176, 1119 and 1023 cm-1; m/z (%): 424(M+, <1), 407(3), 
378(5), 333(3), 91(34), 77(16) and 69(100). 
2-[2-(4-Isopropylphenyl)-1-methylethyl)-3-nitro-4-
phenyl-7-oxa-1-azaspiro[4.4]nonan-6-one (14i) A 
mixture of imine 12i (1.0 g, 3.6 mmol), E-nitrostyrene 
(0.54 g, 3.6 mmol), triethylamine (0.56 mL, 4.0 mmol) and 
silver oxide (0.08 g, 0.36 mmol) in toluene (40 mL, was 
stirred for 5 h. Flash chromatography eluting with 1:1 v/v 
ether:hexane separated the 1:1 mixture of diastereomers 
(combined yield 1.11 g, 72%).  
First eluting isomer: Crystallised from 
dichloromethane/hexane as colourless rods, m.p. 143-145 
°C. Found: C, 71.15; H, 7.25; N, 6.45. C25H30O4N2 
requires: C, 71.10; H, 7.15; N, 6.65 %; δ (1H, 250 MHz): 
7.39-7.34 (m, 3H, Ar-H), 7.15-7.10 (m, 6H, Ar-H), 5.46 
(dd, 1H, J 4.6 and 5.7 Hz, 3-H), 4.43 (d, 1H, J 4.6 Hz, 4-H), 
4.25 (ddd, 1H, J 6.5, 7.5 and 8.7 Hz, 8-CH2), 3.54 (ddd, 1H, 
J 5.8, 7.5 and 8.7 Hz, 8-CH2), 3.14 (m, 1H, 2-H), 3.03-2.83 
(m, 3H, NH and aliphatic-H), 2.59 (dd, 1H, J 8.1 and 14.5 
Hz, aliphatic-CH2), 2.09-1.92 (m, 3H, 9-CH2 and aliphatic-
H), 1.24 (d, 2 x 3H, J 6.9 Hz, 2 x CH3) and 0.97 (d, 3H, J 
6.6 Hz, CH3); νmax (film): 2969, 1772, 1548, 1457, 1370, 
1220 and 1022 cm-1; m/z (%): 422(M+, <1), 407(<1), 
378(13), 332(47), 277(9), 244(10), 170(57), 133(100), 
117(51) and 91(38). 
Second eluting isomer: Crystallised from 
dichloromethane/hexane as colourless rods, m.p. 120-122 
°C. Found: C, 70.95; H, 7.00; N, 6.70. C25H30O4N2 
requires: C, 71.10; H, 7.15; N, 6.65 %; δ (1H, 250 MHz): 
7.42-7.33 (m, 3H, Ar-H), 7.17-7.05 (m, 6H, Ar-H), 5.61 
(dd, 1H, J 5.2 and 6.3 Hz, 3-H), 4.50 (d, 1H, J 5.2 Hz, 4-H), 
4.18 (dt, 1H, J 6.8 and 8.8 Hz, 8-CH2), 3.44 (dt, 1H, J 6.8 
and 8.8 Hz, 8-CH2), 3.31 (m, 1H, 2-H), 2.99-2.77 (m, 3H, 
NH and aliphatic-H), 2.34 (dd, 1H, J 9.8 and 13.2 Hz, 
aliphatic-CH2), 2.06-2.01 (t, 2H, J 6.8 Hz, 9-CH2), 1.90 (m, 
1H, aliphatic-H), 1.24 (d, 2 x 3H, J 7.0 Hz, 2 x CH3) and 
1.01 (d, 3H, J 6.6 Hz, CH3); νmax (film): 2961, 1771, 1652, 
1547, 1507, 1497, 1369 and 1219 cm-1; m/z (%): 422(M+, 
<1), 407(1), 376(9), 332(61), 277(12), 244(15), 170(56) 
and 133(100). 
2-(2-Methyl-4-phenylbutyl)-3-nitro-4-phenyl-7-oxa-1-
azaspiro[4.4]nonan-6-one (14j) Obtained from imine 12j 
(1.0 g, 3.85 mmol), E-nitrostyrene (0.57 g, 3.85 mmol), 
triethylamine (0.6 ml, 4.23 mmol) and silver oxide (0.089 
g, 0.38 mmol) in toluene (40 mL) over 4 h. Purification by 
flash chromatography eluting with 1:1 v/v ether:hexane 
afforded the product (0.93 g, 59%) as a 1:1 mixture of 
diastereomers which crystallised from dichloromethane/ 
hexane as colourless plates, m.p. 75-83 °C. Found: C, 
70.80; H, 6.70; N, 6.60. C24H28O4N2 requires: C, 70.60; H, 
6.90; N, 6.85 %; δ (1H, 250 MHz): 7.38-7.14 (m, 10H, Ar-
H), 5.44 (m, 1H, 3-H), 4.50 (m, 1H, 4-H), 4.13 (m, 1H, 8-
CH2), 3.63 (m, 1H, 2-H), 3.34 (m, 1H, 8-CH2), 2.70-2.47 
(m, 3H, NH and aliphatic-H), 2.09-1.98 (m, 2H, 9-CH2), 
1.73-1.39(m, 5H, aliphatic-H) and 1.04 and 1.0 (d, 3H, J 
6.4 Hz, CH3); νmax (film): 2922, 1770, 1548, 1496, 1455, 
1370, 1270 and 1177 cm-1; m/z (%): 408 (M+, <1), 362(6), 
334(7), 318(70), 304(10), 263(8), 185(14) and 91(100). 
N-Acetylation of Cycloadducts8b 
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Acetic anhydride (11mol equiv., 0.46 mL, 0.5 g, 4.86 
mmol) was added at 0 °C to a solution of cycloadducts 
endo-9q and exo-10q (170 mg, 0.44 mmol) in pyridine (3 
mL). The mixture was stirred at room temperature for 3 h., 
and then poured into ice water. The products were extracted 
with dichloromethane and the organic layer washed 
sequentially with 5 % aqueous HCl, saturated aqueous 
NaHCO3, and brine, dried (MgSO4), and concentrated in 
vacuo. The isomers were separated by column 
chromatography eluting with 3:2 v/v hexane / ethyl acetate. 
Methyl N-acetyl-5-naphthalen-2-yl-4-nitro-3-thiophen-
2-yl-pyrrolidine-2-carboxylate (16a) 
The major isomer (255 mg, 40 %) crystallised as colourless 
prisms from hexane-EtOAc, Rf 0.3, m.p. 203-205 °C.Found: C, 62.25; H, 4.90; N, 6.65; S, 7.70. C22H20N2O5S 
requires C, 62.25; H, 4.75; N, 6.60; S, 7.55 %. δ (1H, 500 
MHz, C6D6) 8.61 (s, 1H, 1′-H), 8.00 (dd, 1H, J 1.1, 8.5 Hz, 
3′-H), 7.98 (m, 1H, ArH), 7.83 (d, 1H, J 8.5 Hz, ArH), 7.74 
(m, 1H, ArH), 7.35 (m, 2H, ArH), 7.06 (dd, 1H, J 1.1, 5.1 
Hz, Ha), 6.99 (d, 1H, J 3.6 Hz, Hc), 6.72 (dd, 1H, J 3.6, 5.1 
Hz, Hb), 6.12 (s, 1H, 5-H), 5.45 (d, 1H, J 6.0 Hz, 4-H), 
5.28 (d, 1H, J 10.9 Hz, 2-H), 4.52 (dd, 1H, J 6.0, 10.9 Hz, 
3-H), 3.44 (s, 3H, CO2CH3), and 1.78 (s, 3H, COCH3). δ 
(13C) 171.9 (ester CO), 171.1 (amide CO), 134.9 (Cq), 
133.8 (2 x Cq), 132.8 (Cq), 130.3, 128.9, 128.2, 127.9, 
127.6 (ArCH), 127.5, 126.8 (2 x ArCH), 123.9 (ArCH), 
96.3 (C4), 66.8 (C5), 64.2 (C2), 53.4 (OCH3), 45.1 (C3), and 
22.4 (CH3). IR (DCM) 2952, 1746, 1663, 1556, 1437, 
1367, 1207, 1178, 860, and 737 cm-1. m/z (ES+) 425 (M+ + 
1, 100). 
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Methyl N-acetyl-5-naphthalen-2-yl-4-nitro-3-thiophen-
2-yl-pyrrolidine-2-carboxylate (16b) 
The minor isomer (166 mg, 26 %) crystalised from hexane-
EtOAc as colourless prisms, Rf 0.2, m.p. 212-214 °C. 
Found: C, 61.95; H, 4.90; N, 6.55; S, 7.60. C22H20N2O5S 
requires C, 62.25; H, 4.75; N, 6.60; S, 7.55 %. δ (1H, 500 
MHz) 7.97 (m, 3H, ArH), 7.87 (m, 2H, ArH), 7.55 (m, 2H, 
ArH), 7.29 (dd, 1H, J 1.0, 5.0 Hz, Ha), 7.00 (d, 1H, J 3.5 
Hz, Hc), 6.97 (dd, 1H, J 3.5, 5.0 Hz, Hb), 5.67 (dd, 1H, J 
8.5, 11.6 Hz, 4-H), 5.49 (d, 1H, J 8.5 Hz, 5-H), 5.19 (d, 1H, 
J 9.4 Hz, 2-H), 4.67 (dd, 1H, J 9.4, 11.6 Hz, 3-H), 3.54 (s, 
3H, CO2CH3), and 1.68 (s, 3H, COCH3). δ (13C) 171.3, 
171.2 (CO), 135.2, 134.1, 133.6, 133.4 (Cq), 130.6, 128.6, 
128.3, 127.7, 127.4 (ArCH), , 127.3 (2 x ArCH), 127.2, 
126.9, 123.8 (ArCH), 95.2 (C4), 67.5 (C2), 64.3 (C3), 52.9 
(C5), 45.6 (OCH3), and 23.2 (CH3). IR (DCM) 2951, 1742, 
1663, 1558, 1437, 1369, 1215, 862, and 752 cm-1. m/z 
(ES+) 448 (M+ + 1 + Na, 30), 446 (M+ + Na, 100). 
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Methyl N-acetyl-3(1-H-indol-3-yl)-5-naphthalen-2-yl-4-
nitro-pyrrolidine-2-carboxylate (17a) 
Prepared by the general method from endo-9c. Trituration 
with ether afforded the product as pale yellow needles (618 
 % Enhancement 
Irradiated 
proton 
H-4 COCH3 H-1′ H-3′ H-5 H-3 Hc
H-5 7.9 9.0 6.1 7.2 - - - 
H-4 - - 1.5 3.2 4.4 13.4 - 
H-3 18.6 - 4.5 2.2 - - 3.2 
H-2 - - 2.6 - 1.1 3.0 10.3 
 % Enhancement 
Irradiated proton H-5 H-4 H-11 H-2 H-3  
H-11 11.3 4.46 1.03 - - - 
H-5 5.6 - 5.28 5.54 2.02 - 
H-4 - 6.47 - - - 14.2 
H-3 - - 14.3 - - - 
H-2 - 3.66 - - - - 
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mg, 90 %), mp 190-192 °C. Found: C, 68.25; H, 5.25; N, 
9.30. C26H23N3O5 requires C, 68.26; H, 5.07; N, 9.18%. δ 
(1H, 250 MHz) 8.41 (s, 1H, indole NH), 8.27 (s, 1H, ArH), 
7.90-7.65 (m, 4H, ArH), 7.60-7.40 (m, 3H, ArH), 7.30 (d, 
1H, J 8.0 Hz, ArH), 7.20-7.05 (m, 3H, ArH), 5.72 (m, 2H, 
5-H + 4-H), 4.83 (d, 1H, J 10.0 Hz, 2-H), 3.78 (t, 1H, J 
10.0 Hz, 3-H), 3.65 (s, 3H, CO2CH3), and 1.83 (s, 3H, 
CH3). δ (13C) 171.9 (ester CO), 171.2 (amide CO), 137.0, 
134.0, 133.6, 132.6 (Cq), 129.6, 128.9, 128.2, 127.8, 127.3, 
127.1 (ArCH), 125.9 (Cq), 124.7, 123.4, 123.2, 120.7, 
118.9, 112.3 (ArCH), 108.5 (Cq), 90.8 (C4), 64.3 (C5), 63.3 
(C2), 53.2 (OCH3), 41.5 (C3), and 22.6 (CH3). IR (DCM) 
3420, 3058, 2951, 1745, 1653, 1558, 1436, 1349, 1214, 
1014, 867, and 744 cm-1. m/z (ES+) 458 (M+ + 1, 100). 
Methyl N-acetyl-3-[4-(acetyloxy)-3-methoxyphenyl]-5-
biphenyl-4-yl-4-nitro-pyrrolidine-2-carboxylate (17b) 
Prepared by the general method from endo-9i. Trituration 
with ether afforded the product as a colourless amorphous 
powder (707 mg, 93%), m.p. 206-208 °C. HRMS found 
533.1918 C29H29N2O8 requires 533.1924. Found: C, 65.70; 
H, 5.35; N, 5.05. C29H28N2O8 requires C, 65.40; H, 5.30; N, 
5.26%. δ (1H, 500 MHz, CDCl3 + C6D6) 7.80 (d, 2H, J 8.3 
Hz, ArH), 7.68 (dd, 2H, J 1.9, 8.3 Hz, ArH), 7.57 (dd, 2H, 
J 1.2, 8.4 Hz, ArH), 7.42 (dd, 2H, J 7.0, 8.4 Hz, ArH), 7.33 
(m, 1H, ArH), 6.94 (d, 1H, J 8.2 Hz, Hc), 6.79 (d, 1 H, J 
1.9 Hz, Ha), 6.72 (dd, 1H, J 1.9, 8.2 Hz, Hb), 5.43 (s, 1H, 
5-H), 5.22 (d, 1H, J 10.8 Hz, 2-H), 5.10 (dd, 1H, J 0.7, 6.2 
Hz, 4-H), 4.02 (dd, 1H, J 10.8, 6.2 Hz, 3-H), 3.71 (s, 3H, 
CO2CH3), 3.70 (s, 3H, ArOCH3), 2.20 (s, 3H, ester CH3), 
and 1.89 (s, 3H, NCOCH3). δ (13C, 125 MHz, CDCl3 + 
C6D6) 171.9 (-CO), 170.6 (amide CO), 168.5 (ester -OCO), 
151.6, 142.2, 140.3, 140.0, 136.5, 129.9 (Cq), 129.0, 128.4 
(2 x ArCH), 127.9 (ArCH), 127.1, 127.0 (2 x ArCH), 
123.5, 120.1, 111.8 (Vanillin ArCH), 96.3 (C4), 66.4 (C5), 
62.2 (C2), 55.9 (ArOCH3), 52.9 (OCH3), 48.7 (C3), 21.9 (N-
acetyl CH3), and 20.5 (O-acetyl CH3). IR (DCM) cm-1 
3248, 3062, 3029, 2953, 1748, 1663, 1554, 1516, 1402, 
1368, 1351, 1264, 1204, 1033, 1009, and 856. m/z (ES+) 
556 (M+ + 1+ Na, 36), 555 (M+ + Na, 100). 
General Procedure for Reduction of the NO2 group 
Zinc dust (135 mg, 2.06 mmol) was added to a stirred 
solution of nitro compound (52 mg, 0.12 mmol) in ethanol 
(10 ml). The mixture was then heated to 40-45 °C and 
conc. HCl (0.2 ml) was added keeping the temperature in 
between 45-50 °C. The reaction mixture was then refluxed 
for 12 h, filtered, and the filtrate evaporated in vacuo nearly 
to dryness. The residue was extracted with DCM and 
saturated NaHCO3 solution was added until the pH was 
slightly basic and then extracted with more DCM. The 
combined DCM extracts were dried (MgSO4), filtered and 
the filtrate evaporated under reduced pressure. 
Methyl N-acetyl-4-amino-5-naphthalene-2-yl-3-
thiophen-2-yl-pyrrolidine-2-carboxylate (18a) 
Flash column chromatography eluting with ethyl acetate 
followed by 3:1 v/v methanol/ hexane afforded the product 
as colourless plates (347 mg, 88 %), Rf 0.33, m.p. 81-83 °C. 
Found: C, 66.70; H, 5.70; N, 6.85; S, 8.00. C22H22N2O3S 
requires C, 66.98; H, 5.62; N, 7.10; S, 8.13 %. δ (1H, 250 
MHz) 8.07 (s, 1H, ArH), 7.75-7.51 (m, 3H, ArH), 7.35-
7.30 (m, 2H, ArH), 7.10-7.05 (m, 1H, ArH), 6.85-6.80 (m, 
2H, ArH), 4.79 (d, 1H, J 7.4 Hz, 5-H), 4.66 (d, 1H, J 4.6 
Hz, 2-H), 3.78 (dd, 1H, J 4.6, 7.4 Hz, 4-H), 3.63 (s, 3H, 
CO2CH3), 3.47 (t, 1H, J 4.6 Hz, 3-H), and 1.69 (s, 3H, 
CH3). δ (13C) 172.5, 171.8 (CO), 138.0, 137.6, 133.8, 133.4 
(Cq), 129.5, 128.6, 128.1, 127.6, 127.1, 126.9, 126.8, 126.3, 
125.6, 124.7 (ArCH), 70.7 (C4), 64.3 (C2), 63.8 (C3), 53.0 
(C5), 46.4 (OCH3), and 22.7 (CH3). IR (DCM) 2950, 1743, 
1653, 1559, 1436, 1406, 1351, 1201, 861, and 755 cm-1. 
m/z (ES+) 396 (M+ + 2), 395 (M+ + 1, 100). 
Methyl N-acetyl-4-amino-5-naphthalene-2-yl-3-
thiophen-2-yl-pyrrolidine-2-carboxylate (18b) 
Trituration with ether afforded the product as a colourless 
amorphous powder (375 mg, 95 %), m.p. 209-211 °C. 
HRMS found 395.1429 C22H22N2O3S requires 395.1424. 
Found: C, 66.40; H, 5.75; N, 6.90. C22H22N2O3S requires C, 
66.98; H, 5.62; N, 7.10 %. δ (1H, 250 MHz) 8.07 (s, 1H, 
ArH), 7.75-7.51 (m, 3H, ArH), 7.35-7.30 (m, 2H, ArH), 
7.10-7.05 (m, 1H, ArH), 6.85-6.80 (m, 2H, ArH), 4.79 (d, 
1H, J 7.4 Hz, 5-H), 4.66 (d, 1H, J 4.6 Hz, 2-H), 3.78 (dd, 
1H, J 4.6, 7.4 Hz, 4-H), 3.63 (s, 3H, CO2CH3), 3.47 (t, 1H, 
J 4.6 Hz, 3-H), and 1.69 (s, 3H, CH3). δ (13C) 172.5, 171.8 
(CO), 138.0, 137.6, 133.8, 133.4 (Cq), 129.5, 128.6, 128.1, 
127.6, 127.1, 126.9, 126.8, 126.3, 125.6, 124.7 (ArCH), 
70.7 (C4), 64.3 (C2), 63.8 (C3), 53.0 (C5), 46.4 (OCH3), and 
22.7 (CH3). IR (DCM) 3058, 2949, 1740, 1652, 1559, 
1436, 1403, 1351, 1201, 861, and 754 cm-1. m/z (ES+) 396 
(M+ + 2), 395 (M+ + 1, 100). 
Supplementary information 
 
Crystallographic data (excluding structural factors) for the 
structures in this paper have been deposited at the 
CambridgeCrystallographic Data Centre as supplementary 
publication nos. CCDC 682218 (compound 14a), CCDC 
682219 (15a), CCDC 682220 (16a), and CCDC 682221 
(16b). 
Copies of the data can be obtained, free of charge, on  
application to CCDC, 12 Union Road, Cambridge  
CB2 1EZ, UK (fax: +44 (0) 1223 336033 or via the web at:  
http://www.ccdc.cam.ac.uk/products/csd/request/). 
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